<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-04-06">6 April 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>Dr</roleName><forename type="first">Martin</forename><surname>Schmidt-Hieber</surname></persName>
							<email>martin.schmidt-hieber@helios-kliniken.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">HELIOS Clinic Berlin-Buch</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Silling</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Hematology, Oncology and Stem Cell Transplantation</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">University Hospital</orgName>
								<address>
									<settlement>Aachen</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">RWTH Aachen</orgName>
								<address>
									<settlement>Aachen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Schalk</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Hematology and Oncology</orgName>
								<orgName type="institution">Otto-von-Guericke University Hospital Magdeburg</orgName>
								<address>
									<settlement>Magdeburg</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">W</forename><surname>Heinz</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Internal Medicine II</orgName>
								<orgName type="department" key="dep2">Center of Internal Medicine</orgName>
								<orgName type="institution">University Hospital Würzburg</orgName>
								<address>
									<settlement>Würzburg</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Panse</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Hematology, Oncology and Stem Cell Transplantation</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">University Hospital</orgName>
								<address>
									<settlement>Aachen</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">RWTH Aachen</orgName>
								<address>
									<settlement>Aachen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">O</forename><surname>Penack</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">Charité University Medicine</orgName>
								<address>
									<addrLine>Campus Virchow Clinic</addrLine>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Christopeit</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Stem Cell Transplantation</orgName>
								<orgName type="institution">University Medical Center Hamburg Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">D</forename><surname>Buchheidt</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Hematology and Oncology</orgName>
								<orgName type="institution" key="instit1">Mannheim University Hospital</orgName>
								<orgName type="institution" key="instit2">University of Heidelberg</orgName>
								<address>
									<settlement>Mannheim</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">U</forename><surname>Meyding-Lamadé</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Department of Neurology</orgName>
								<orgName type="institution">Hospital Nordwest Frankfurt</orgName>
								<address>
									<settlement>Frankfurt/M</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">Brunei Neuroscience Stroke and Rehabilitation Centre</orgName>
								<address>
									<settlement>Jerudong, Brunei Darussalam</settlement>
								</address>
							</affiliation>
							<affiliation key="aff10">
								<orgName type="department">Department of Neuroinfectiology</orgName>
								<orgName type="institution" key="instit1">Otto-Meyerhof-Centre</orgName>
								<orgName type="institution" key="instit2">University of Heidelberg</orgName>
								<address>
									<settlement>Heidelberg</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Hähnel</surname></persName>
							<affiliation key="aff11">
								<orgName type="department">Department of Neuroradiology</orgName>
								<orgName type="institution">University Hospital Heidelberg</orgName>
								<address>
									<settlement>Heidelberg</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Wolf</surname></persName>
							<affiliation key="aff12">
								<orgName type="department">Department of Hematology and Oncology</orgName>
								<orgName type="institution">University Hospital Halle</orgName>
								<address>
									<settlement>Halle</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Ruhnke</surname></persName>
							<affiliation key="aff13">
								<orgName type="institution">Paracelsus Clinic Osnabrück</orgName>
								<address>
									<settlement>Osnabrück</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
							<affiliation key="aff14">
								<orgName type="department">Department of Hematology and Oncology</orgName>
								<orgName type="institution">Charité University Medicine</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Maschmeyer</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Hematology, Oncology and Palliative Care</orgName>
								<orgName type="institution">Ernst von Bergmann Clinic</orgName>
								<address>
									<settlement>Potsdam</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="department">Clinic for Hematology, Oncology and Tumor Immunology</orgName>
								<orgName type="institution">HELIOS Clinic Berlin-Buch</orgName>
								<address>
									<addrLine>Schwanebecker Chaussee 50</addrLine>
									<postCode>13125</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-04-06">6 April 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">6E484F1B6E44E45CCB4D8FF6D2364B36</idno>
					<idno type="DOI">10.1093/annonc/mdw155</idno>
					<note type="submission">Received 3 December 2015; revised 21 March 2016; accepted 24 March 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:19+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>guideline</term>
					<term>central nervous system infection</term>
					<term>immunocompromised patient</term>
					<term>diagnosis</term>
					<term>treatment</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Infections of the central nervous system (CNS) are infrequently diagnosed in immunocompetent patients, but they do occur in a significant proportion of patients with hematological disorders.</s><s>In particular, patients undergoing allogeneic hematopoietic stem-cell transplantation carry a high risk for CNS infections of up to 15%.</s><s>Fungi and Toxoplasma gondii are the predominant causative agents.</s><s>The diagnosis of CNS infections is based on neuroimaging, cerebrospinal fluid examination and biopsy of suspicious lesions in selected patients.</s><s>However, identification of CNS infections in immunocompromised patients could represent a major challenge since metabolic disturbances, side-effects of antineoplastic or immunosuppressive drugs and CNS involvement of the underlying hematological disorder may mimic symptoms of a CNS infection.</s><s>The prognosis of CNS infections is generally poor in these patients, albeit the introduction of novel substances (e.g.</s><s>voriconazole) has improved the outcome in distinct patient subgroups.</s><s>This guideline has been developed by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) with the contribution of a panel of 14 experts certified in internal medicine, hematology/oncology, infectious diseases, intensive care, neurology and neuroradiology.</s><s>Grades of recommendation and levels of evidence were categorized by using novel criteria, as recently published by the European Society of Clinical Microbiology and Infectious Diseases.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>introduction Infections of the central nervous system (CNS) occur in a relevant proportion of immunocompromised patients and contribute significantly to morbidity and mortality.</s><s>Only limited data are available on the clinical characteristics, optimal diagnostic procedures and treatment of CNS infections in these patients, and studies on CNS infections frequently focused on specific causative agents or distinct patient subgroups such as recipients of allogeneic hematopoietic stem-cell transplantation (allo-HSCT) <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s></p><p><s>This guideline focuses on patients with hematological malignancies including allo-HSCT recipients defined as 'patients with hematological disorders' hereafter.</s><s>Patients with nonmalignant hematological disorders (e.g.</s><s>aplastic anemia) or solid tumors are not specifically excluded albeit CNS infections are very rare in these patients and larger analyses focusing on CNS infections in these subgroups are lacking.</s><s>In the first part of this guideline, an overview on epidemiology, causative agents, risk factors, pathogenesis, prophylaxis in addition to general diagnostic strategies and management of CNS infections is given.</s><s>The second part focuses on distinct infectious agents.</s><s>For recommendations on diagnosis and treatment of bacterial CNS infections (including tuberculous meningitis), see supplementary Material, available at Annals of Oncology online.</s><s>The strengths of recommendation and levels of evidence were categorized according to the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) criteria (Table <ref type="table" target="#tab_0">1</ref>) <ref type="bibr" target="#b2">[3]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>consensus process</head><p><s>See supplementary Material, available at Annals of Oncology online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>epidemiology and causative agents</head><p><s>Patients undergoing allo-HSCT are among those with the highest risk for CNS infections with an overall incidence of up to 15% <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b4">5]</ref>.</s><s>Aspergillus and Toxoplasma spp.</s><s>are frequently prevailing in these patients <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>Patients after an alemtuzumab-based conditioning before allo-HSCT carry a considerable risk for viral CNS infections <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b6">7]</ref>.</s><s>Mucormycosis is diagnosed in ∼0.1% of all patients with hematological disorders, but an increased incidence (1.0%-1.9%)</s><s>has been reported among patients with acute myeloid leukemia <ref type="bibr" target="#b7">[8]</ref>.</s><s>The lungs are frequently infected in mucormycosis, but the CNS might be involved in 10%-20% of patients <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s><s>Progressive multifocal leukencephalopathy (PML) is a rare (&lt;1%), but frequently fatal CNS disease caused by the JC virus.</s><s>It mainly affects allo-HSCT recipients, but also patients after rituximab-based treatment strategies or with multiple lines of immunosuppression <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12]</ref>.</s><s>Bacterial CNS infections are rarely diagnosed in patients with hematological disorders, and they occur more frequently in patients with intraventricular devices or after neurosurgical interventions <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref>.</s><s>prophylaxis Prophylactic strategies should follow recommendations for immunocompromised patients as published elsewhere <ref type="bibr" target="#b15">[16,</ref><ref type="bibr" target="#b16">17]</ref>.</s><s>Patients with hematological disorders requiring intracerebral devices such as an external ventricular drainage could benefit from antimicrobial-impregnated catheters since they might be associated with a lower infection rate in comparison to standard catheters <ref type="bibr" target="#b14">[15]</ref>.</s></p><p><s>general strategies to diagnose and to treat CNS infections in patients with hematological disorders Some principal aspects regarding the management of CNS infections in patients with hematological disorders should be considered:</s></p><p><s>(i) The management of CNS infections in patients with hematological disorders requires a high level of awareness, as neurological symptoms could be nonspecific and caused by noninfectious conditions related to the underlying disease and/or side-effects of antineoplastic or immunosuppressive treatment <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b13">14]</ref>.</s><s>(ii) While clinical presentations of CNS infections in immunocompetent hosts are broadly categorized into meningitis, meningoencephalitis, cerebritis/abscess formation and infection of intracerebral devices, diminished inflammatory responses in immunocompromised patients can lead to only subtle symptoms.</s><s>Mass lesions can be blurred by rather nonspecific cerebral dysfunctions such as confusion or altered consciousness <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b13">14]</ref>.</s><s>(iii) Defined patient groups predispose for infections with certain pathogens based on their pattern of immunosuppression (defects in cell-mediated immunity versus defective humoral immunity) <ref type="bibr" target="#b17">[18,</ref><ref type="bibr" target="#b18">19]</ref>.</s><s>Bacterial, fungal and viral CNS infections typically occur in neutropenic patients.</s><s>Defects in T-cell immunity or in function of macrophages predispose for cerebral toxoplasmosis and cryptococcal meningitis <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b17">18,</ref><ref type="bibr" target="#b19">20]</ref>.</s><s>(iv) Variations in the frequency of causative organisms (e.g.</s></p><p><s>Toxoplasma spp.</s><s>Histoplasma capsulatum, Mycobacterium tuberculosis) due to regional endemic differences should be taken into account <ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref>.</s><s>Neuroimaging should commonly be based on magnetic resonance imaging (MRI) since it is more sensitive than computed tomography (CT) scan for diagnosis of the majority of CNS infections <ref type="bibr" target="#b103">[102]</ref><ref type="bibr" target="#b104">[103]</ref><ref type="bibr" target="#b105">[104]</ref><ref type="bibr" target="#b106">[105]</ref>.</s></p><p><s>Further diagnostic methods such as positron emission tomography might help in selected patients to differentiate infectious from noninfectious CNS lesions <ref type="bibr" target="#b107">[106]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>antimicrobial treatment</head><p><s>Given the dismal outcome of delayed treatment in patients with hematological disorders and CNS infection, antimicrobial treatment should be initiated promptly once collection of CSF and blood cultures has been completed (Figure <ref type="figure" target="#fig_1">1</ref>) <ref type="bibr" target="#b108">[107]</ref><ref type="bibr" target="#b109">[108]</ref><ref type="bibr" target="#b110">[109]</ref>.</s><s>After isolation and in vitro susceptibility testing of a ( potentially) causative pathogen, antimicrobial treatment should be modified accordingly.</s><s>Recommendations for empiric, pre-emptive and targeted treatment are specified in Figure <ref type="figure" target="#fig_1">1</ref>, Table <ref type="table" target="#tab_4">3</ref>  Directed treatment: Should be initiated immediately after isolation of a (potential) causative organism and follow the recommendations specified in Table <ref type="table" target="#tab_4">3</ref> Empirical/preemptive treatment: 3 rd generation cephalosporin or meropenem + ampicillin +/vancomycin +/-acyclovir (if viral encephalitis is suspected) Stereotactic brain biopsy/neurosurgical resection of brain lesions (if technically possible) followed by identification and resistance testing of potential causative organisms *The decision on brain biopsy/neurosurgical resection should always be made on the basis of the technical feasibility, the suspicious causative agent, and other factors (such as presence of thrombocytopenia).</s><s>For example, brain biopsy might not be required to establish the diagnosis of PML in patients with typical neuroimaging findings together with a positive CSF JC virus PCR.</s><s>Anti-infective agents should be given for ∼6 weeks in indicated dosages, then as maintenance therapy half of the original dosage for at least 3 months Pyrimethamine should be combined with folinic acid <ref type="bibr" target="#b111">[110]</ref> Pyrimethamine (orally, 100-200 mg load, then 50 mg/day) + clindamycin (orally or i.v., 600 mg q6h) BII t <ref type="bibr" target="#b112">[111]</ref><ref type="bibr" target="#b113">[112]</ref><ref type="bibr" target="#b114">[113]</ref> Trimethoprim (10 mg/kg/day)sulfamethoxazole (orally or i.v.)</s></p><p><s>BII t <ref type="bibr" target="#b115">[114]</ref> Atovaquone (orally, e.g.</s><s>750 mg q6h) BII t,u Might be used for maintenance in patients intolerant to conventional antitoxoplasmic agents, could be combined as primary treatment with pyrimethamine or sulfadiazine <ref type="bibr" target="#b116">[115,</ref><ref type="bibr" target="#b117">116]</ref> Fungi Ganciclovir (i.v., 5 mg/kg q12h) + foscarnet (i.v., 60 mg/kg q8h or 90 mg/kg q12h) BIII <ref type="bibr" target="#b190">[188,</ref><ref type="bibr" target="#b197">[195]</ref><ref type="bibr" target="#b198">[196]</ref><ref type="bibr" target="#b199">[197]</ref> Cidofovir (i.v., optimal dosage unclear, e.g. 5 mg/kg once weekly) CIII <ref type="bibr" target="#b200">[198,</ref><ref type="bibr" target="#b201">199]</ref> Ganciclovir (i.v., 5 mg/kg q12h) + cidofovir (i.v., e.g. 5 mg/kg once weekly) CIII <ref type="bibr" target="#b197">[195,</ref><ref type="bibr" target="#b202">200]</ref> Foscarnet (i.v., 60 mg q8h or 90 mg/kg q12h) + cidofovir (i.v., e.g.</s><s><ref type="bibr" target="#b227">[224,</ref><ref type="bibr" target="#b228">225]</ref> Due to the lack of systematic data, decisions about the duration of antimicrobial treatment should be assessed individually.</s><s>Hereby, the strategy of treatment (such as antimicrobial drug therapy with or without surgery), resolution of symptoms and recovery of the individual immune-status, as defined by the presence of neutropenia, hypogammaglobulinemia and graftversus-host disease should be taken in account.</s><s>In patients with persisting complex immunodeficiencies, targeted antimicrobial treatment might be followed by maintenance treatment (e.g. for cerebral toxoplasmosis).</s><s>To improve efficacy and minimize toxicity, therapeutic drug monitoring (TDM) might be useful for antimicrobial agents, such as 5-fluorocytosine (5-FC), voriconazole and posaconazole [BII] <ref type="bibr" target="#b232">[229,</ref><ref type="bibr" target="#b233">230]</ref>.</s><s>TDM might be of particular relevance in patients with hematological disorders since impaired gastrointestinal resorption and interferences with co-medication are common in this population <ref type="bibr" target="#b233">[230]</ref><ref type="bibr" target="#b234">[231]</ref><ref type="bibr" target="#b235">[232]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>adjunctive treatment</head><p><s>Adjunctive treatment may include neurosurgery, platelet transfusion and administration of corticosteroids, anticonvulsants, sedatives or antipyretics (see supplementary Material, available at Annals of Oncology online).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CNS infections related to specific causative agents parasitic CNS infections</head><p><s>Toxoplasma spp.</s><s>belong to the most common causative agents in allo-HSCT recipients with CNS infections <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b5">6]</ref>.</s><s>However, other parasitic CNS infections such as malaria, microsporidiosis, leishmaniasis, trypanosomiasis or helminthic infections have also been described in immunocompromised hosts <ref type="bibr" target="#b236">[233]</ref>.</s></p><p><s>Toxoplasma spp.</s><s>Mental abnormalities, fatigue and fever are frequent clinical symptoms in allo-HSCT recipients with cerebral toxoplasmosis <ref type="bibr" target="#b237">[234]</ref>.</s><s>Neuroimaging by MRI frequently shows typical hypo-/isointensities mainly in the basal ganglia and the frontal lobe (supplementary Figure <ref type="figure" target="#fig_1">S1</ref>, available at Annals of Oncology online) <ref type="bibr" target="#b106">[105]</ref>.</s><s>Higher sensitivity of MRI compared with CT scan has been demonstrated in a comparative retrospective analysis <ref type="bibr" target="#b105">[104,</ref><ref type="bibr" target="#b106">105]</ref>.</s><s>However, typical nodular or ring enhancement surrounded by edema was visible by MRI in only 60% of allo-HSCT patients <ref type="bibr" target="#b238">[235]</ref>  <ref type="bibr" target="#b31">[32,</ref><ref type="bibr" target="#b152">150,</ref><ref type="bibr" target="#b240">237]</ref>.</s><s>MRI may show ring-enhanced lesions, infarction and dural or vascular infiltration from adjacent regions (supplementary Figure <ref type="figure">S2</ref>, available at Annals of Oncology online) <ref type="bibr" target="#b241">[238,</ref><ref type="bibr" target="#b242">239]</ref>.</s><s>A definitive diagnosis frequently requires biopsy of suspicious lesions and demonstration of typical septate hyphae [A] <ref type="bibr" target="#b29">[30,</ref><ref type="bibr" target="#b30">31]</ref>.</s><s>Several studies indicate that detection of CSF galactomannan [B] or the PCR assay [B] might also be useful to diagnose CNS aspergillosis <ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b37">37]</ref>.</s><s>In Aspergillus meningitis, CSF galactomannan might be detected in almost 90% of cases, whereas fungal cultures are positive in ∼30% <ref type="bibr" target="#b31">[32]</ref>.</s><s>CSF fungal cultures are usually negative in patients with Aspergillus CNS infection other than meningitis <ref type="bibr" target="#b31">[32]</ref>.</s></p><p><s>Voriconazole is the drug of choice in CNS aspergillosis, as this azole displays sufficient penetration into the CNS [AII u ] <ref type="bibr" target="#b118">[117,</ref><ref type="bibr" target="#b119">118,</ref><ref type="bibr" target="#b243">240]</ref>.</s><s>Amphotericin B deoxycholate (D-AmB) should be avoided due to its poor tolerability and negligible efficacy [DII u ], but the use of higher doses of liposomal AmB (L-AmB) resulted in successful outcomes in a limited number of patients [BIII] <ref type="bibr" target="#b120">[119]</ref><ref type="bibr" target="#b121">[120]</ref><ref type="bibr" target="#b122">[121]</ref><ref type="bibr" target="#b124">[122]</ref><ref type="bibr" target="#b125">[123]</ref><ref type="bibr" target="#b136">134]</ref>.</s><s>Due to its limited CNS penetration and the limited number of successfully treated cases in the literature, the use of itraconazole does not appear justifiable in patients with CNS aspergillosis [DIII] <ref type="bibr" target="#b129">[127]</ref><ref type="bibr" target="#b130">[128]</ref><ref type="bibr" target="#b131">[129]</ref>.</s><s>Posaconazole has been used in a series of patients with CNS infections caused by various fungi, including three assessable patients with CNS aspergillosis [DIII] <ref type="bibr" target="#b134">[132]</ref>.</s><s>Caspofungin has demonstrated some activity in a mouse model exploring CNS aspergillosis, but clinical data on the use of echinocandins in CNS aspergillosis are scarce <ref type="bibr" target="#b132">[130,</ref><ref type="bibr" target="#b133">131]</ref>.</s><s>Some animal model data suggest that combination therapy (e.g.</s><s>voriconazole with L-AmB) might be beneficial, but meaningful clinical data are not available to recommend the use of combination therapies in CNS aspergillosis [DIII] <ref type="bibr" target="#b244">[241,</ref><ref type="bibr" target="#b245">242]</ref>.</s></p><p><s>Intrathecal or intralesional administration of AmB has been repeatedly been applied to patients with CNS aspergillosis, but published data are limited to case reports [DIII] <ref type="bibr" target="#b246">[243,</ref><ref type="bibr" target="#b247">244]</ref>.</s><s>In addition, intrathecal D-AmB could cause chemical arachnoiditis and it is unlikely that sufficient drug concentration is achieved in infected brain tissues <ref type="bibr" target="#b248">[245]</ref>.</s><s>Adjunctive corticosteroid therapy could reduce mass effects and brain edema, but should be avoided whenever possible due to its deleterious effects in invasive fungal infections <ref type="bibr" target="#b249">[246]</ref>.</s><s>If corticosteroid therapy is unavoidable, prednisolone should be preferred over dexamethasone, as dexamethasone is associated with low voriconazole levels (S.</s><s>Schwartz, personal communication).</s></p><p><s>Neurosurgical interventions could facilitate diagnostic confirmation and contribute to a successful outcome, likely by removing infarcted areas with poor drug penetration [BII u ] <ref type="bibr" target="#b118">[117,</ref><ref type="bibr" target="#b119">118,</ref><ref type="bibr" target="#b138">136,</ref><ref type="bibr" target="#b139">137]</ref>.</s><s>Candida spp.. Candida CNS infections typically present as meningoencephalitis or as ventriculitis associated with foreign bodies such as shunts or, rarely, as brain abscesses.</s><s>Candida microabscesses could be discovered at autopsy, while CT and CSF analysis not always show clearly pathological findings in this situation <ref type="bibr" target="#b44">[44]</ref>.</s><s>Neuroimaging might show hydrocephalus in Candida meningitis and MRI is considered to be more sensitive than CT scan <ref type="bibr" target="#b44">[44,</ref><ref type="bibr" target="#b149">147]</ref>.</s><s>In the case of Candida meningitis, yeasts can be detected by CSF staining in ∼40% and in ∼40%-80% by fungal cultures [A] <ref type="bibr" target="#b44">[44,</ref><ref type="bibr" target="#b45">45]</ref>.</s><s>The PCR technique as well as the detection of (1 → 3)-β-D-Glucan or the Candida mannan antigen might also be useful to diagnose Candida meningitis from CSF, but these methods are not yet considered as clinical routine procedures [C] <ref type="bibr" target="#b38">[38,</ref><ref type="bibr" target="#b46">46,</ref><ref type="bibr" target="#b47">47,</ref><ref type="bibr" target="#b49">49]</ref>.</s></p><p><s>Most data on the treatment of Candida CNS infection are derived from pediatric patients.</s><s>The use of D-AmB with 5-FC has been suggested as the optimal initial therapy for many years due to the excellent CSF penetration of 5-FC, the documented synergism of both compounds in vitro and in vivo and their documented clinical activity in Candida infections <ref type="bibr" target="#b44">[44,</ref><ref type="bibr" target="#b152">150]</ref>.</s><s>The rationale for the use of L-AmB is mainly reasoned by studies in experimental Candida meningoencephalitis and clinical data from preterm newborns <ref type="bibr" target="#b142">[140,</ref><ref type="bibr" target="#b143">141,</ref><ref type="bibr" target="#b250">247,</ref><ref type="bibr" target="#b251">248]</ref>.</s><s>Since L-AmB has an improved toxicity profile compared with D-AmB, the combination of L-AmB and 5-FC should be preferred to treat Candida CNS infections <ref type="bibr">[BIII]</ref>.</s><s>Fluconazole, alone or in combination with 5-FC, may be used as an oral consolidation therapy <ref type="bibr">[BIII]</ref>.</s><s>Voriconazole is a reasonable therapeutic option for Candida CNS infection [CIII] <ref type="bibr" target="#b147">[145,</ref><ref type="bibr" target="#b252">249]</ref>.</s><s>Animal models suggest the potential usefulness of the echinocandins in Candida CNS infection, although higher doses might be required (as studied for micafungin) <ref type="bibr" target="#b153">[151]</ref>.</s><s>Clinical data are limited to case reports; thus this approach cannot be recommended for routine use yet [DIII] <ref type="bibr" target="#b154">[152]</ref>.</s><s>Any indwelling device such as a ventricular drain or a central venous line should be removed in invasive Candida infection [BIII] <ref type="bibr" target="#b253">[250,</ref><ref type="bibr" target="#b254">251]</ref>.</s></p><p><s>mucorales.</s><s>Mucormycosis is a rare opportunistic infection mainly caused by Rhizopus spp.</s><s>and Mucor spp.</s><s><ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b158">156]</ref>.</s><s>The brain might be involved in a disseminated infection or by infiltration from adjacent rhino-sinu-orbital regions <ref type="bibr">[8-10, 154, 156]</ref>.</s><s>Clinical symptoms such as facial pain or swelling may be nonspecific but are frequently present in patients with rhinocerebral mucormycosis <ref type="bibr" target="#b160">[158]</ref>.</s><s>The CT scan frequently reveals characteristic bone destruction of the paranasal sinuses, the hard palate or adjacent structures <ref type="bibr" target="#b255">[252]</ref>.</s><s>The diagnosis should always be confirmed by a histopathological examination and/or culturing of tissue specimens <ref type="bibr">[A]</ref>.</s><s>Histopathological examination of infected tissue typically shows the irregular fungal hyphae with wide-angle branching, in addition to tissue necrosis and fungal angioinvasion <ref type="bibr" target="#b53">[53]</ref>.</s><s>PCR assays using infected tissue specimens [B] or blood [C] have also been evaluated to diagnose mycormycosis <ref type="bibr" target="#b54">[54,</ref><ref type="bibr" target="#b55">55,</ref><ref type="bibr" target="#b57">57]</ref>.</s><s>However, these methods are not standardized yet.</s></p><p><s>Single-agent L-AmB is recommended to treat mucormycosis [AII t,u ], but some experts suggest a primary polyene-caspofungin combination [CIII] <ref type="bibr" target="#b160">[158]</ref><ref type="bibr" target="#b161">[159]</ref><ref type="bibr" target="#b162">[160]</ref>.</s><s>Immediate surgical resection of necrotic tissue may be crucial in addition to antifungal treatment in invasive mucormycosis [AII t,u ] <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b156">154,</ref><ref type="bibr" target="#b157">155]</ref>.</s><s>Besides reduction of immunosuppressive drugs conditions associated with the occurrence of mucormycosis such as hyperglycemia, lactic acidosis and iron overload should be corrected whenever possible <ref type="bibr">[BIII]</ref>.</s><s>However, a placebo-controlled trial exploring L-AmB together with the iron chelating agent deferasirox was terminated prematurely due to inefficacy, despite the crucial role of iron in the pathogenesis of mucormycosis [DII t ] <ref type="bibr" target="#b256">[253]</ref>.</s><s>Posaconazole [BIII] or isavuconazole [CIII] might be used as salvage treatment of mucormycosis <ref type="bibr" target="#b169">[167]</ref><ref type="bibr" target="#b170">[168]</ref><ref type="bibr" target="#b171">[169]</ref><ref type="bibr" target="#b172">[170]</ref>. Hyperbaric oxygen has been investigated as primary or salvage treatment of mucormycosis <ref type="bibr" target="#b257">[254]</ref><ref type="bibr" target="#b258">[255]</ref><ref type="bibr" target="#b259">[256]</ref>.</s><s>This approach is available only in some centers and there are no larger trials confirming its benefit [CIII].</s></p><p><s>Cryptococcus spp.</s><s>Reports from human immunodeficiency virus (HIV)-negative patients with hematological disorders and infection with Cryptococcus spp.</s><s>are limited <ref type="bibr" target="#b260">[257,</ref><ref type="bibr" target="#b261">258]</ref>.</s><s>Neuroimaging by MRI may show dilated Virchow-Robin spaces, cyst-like structures and granuloma of the choroid plexus <ref type="bibr" target="#b262">[259]</ref>.</s><s>A definitive diagnosis of cryptococcal meningitis is made by CSF cultures [A] or CSF microscopy using India Ink staining [A] <ref type="bibr" target="#b58">[58]</ref><ref type="bibr" target="#b59">[59]</ref><ref type="bibr" target="#b60">[60]</ref><ref type="bibr" target="#b62">62]</ref>.</s><s>The diagnosis might further be confirmed by detection of capsular antigen using different techniques such as enzyme immune assays, latex agglutination or the lateral flow assay [A] <ref type="bibr" target="#b58">[58,</ref><ref type="bibr" target="#b61">61]</ref>.</s><s>Likewise, CSF (nested) PCR assays might be used to diagnose cryptococcal meningitis [B] <ref type="bibr" target="#b58">[58,</ref><ref type="bibr" target="#b61">61]</ref>.</s><s>Biopsy of infected tissues followed by culturing and histopathological investigation is required only in selected cases [C] <ref type="bibr" target="#b60">[60]</ref>.</s></p><p><s>Primary treatment of cryptococcal meningitis should encompass a combination of L-AmB and 5-FC [AII t ] <ref type="bibr" target="#b173">[171,</ref><ref type="bibr" target="#b174">172,</ref><ref type="bibr" target="#b183">181,</ref><ref type="bibr" target="#b263">260]</ref>.</s><s>Voriconazole or posaconazole may be used for salvage treatment [CIII] <ref type="bibr" target="#b134">[132,</ref><ref type="bibr" target="#b182">180,</ref><ref type="bibr" target="#b185">183]</ref>.</s><s>Cryptococcus spp.</s><s>are in vitro resistant to echinocandines <ref type="bibr" target="#b186">[184]</ref>.</s><s>Thus, these agents do not play a role in the treatment of cryptococcal meningitis <ref type="bibr">[DIII]</ref>.</s><s>Reducing the CSF opening pressure (e.g. by repetitive lumbar punctures) is useful besides anti-infectious drug therapy in selected patients with cryptococcal meningitis [BII] <ref type="bibr" target="#b174">[172,</ref><ref type="bibr" target="#b264">261]</ref>.</s></p><p><s>viruses Herpes viruses, in particular herpes simplex virus (HSV), Epstein-Barr virus (EBV) and human herpes virus-6 (HHV-6) are prevailing in allo-HSCT recipients <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b73">73]</ref>.</s><s>Viral CNS infections typically present as meningoencephalitis, but strokes-e.g.</s><s>caused by varicella zoster virus (VZV)-or leukoencephalopathy (e.g.</s><s>JC virus-associated PML) might occur <ref type="bibr" target="#b17">[18]</ref>.</s><s>The diagnosis of viral CNS infections is usually made by CSF PCR together with neuroimaging, preferably MRI <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b110">109,</ref><ref type="bibr" target="#b265">262]</ref>.</s></p><p><s>CSF viral PCR assays have an excellent sensitivity and specificity of 90%-100% for the majority of virus types <ref type="bibr" target="#b64">[64,</ref><ref type="bibr" target="#b65">65]</ref>.</s><s>Thus, CSF PCR is regarded as a 'gold standard' for diagnosis of viral CNS infections <ref type="bibr">[A]</ref>.</s><s>However, studies comparing viral isolation from autopsy samples or brain-biopsy specimens-the former reference standard-with PCR are available only for few viruses such as HSV or cytomegalovirus (CMV) <ref type="bibr" target="#b64">[64,</ref><ref type="bibr" target="#b65">65,</ref><ref type="bibr" target="#b70">70]</ref>.</s><s>CSF virus PCR might initially be false-negative and the probability of a positive PCR increases when there is a time frame of 3-14 days between onset of symptoms and lumbar puncture <ref type="bibr" target="#b266">[263]</ref>.</s><s>herpes simplex virus.</s><s>The incidence of HSV encephalitis is relatively low in patients with hematological disorders and there have been few cases published which mainly include allo-HSCT recipients <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b73">73,</ref><ref type="bibr" target="#b267">264]</ref>.</s></p><p><s>CSF PCR is a rapid method to diagnose HSV encephalitis with high sensitivity and specificity (both &gt;90%) [A] <ref type="bibr" target="#b64">[64,</ref><ref type="bibr" target="#b65">65]</ref>.</s><s>Detection of CSF HSV antibodies is not a reliable diagnostic tool for HSV encephalitis since the sensitivity and specificity is only 75%-85% and 60%-90%, respectively [C] <ref type="bibr" target="#b66">[66]</ref>.</s><s>Detection of CSF HSV antigen has a sensitivity and a specificity of ∼90% and might be of value as an adjunctive test [C] <ref type="bibr" target="#b66">[66,</ref><ref type="bibr" target="#b67">67]</ref>.</s><s>CSF viral cultures are frequently negative in HSV encephalitis [D] <ref type="bibr" target="#b68">[68]</ref>.</s><s>Cerebral MRI typically shows abnormalities in the medial and inferior temporal lobe, the insula and the cingulate (supplementary Figure <ref type="figure">S3</ref>, available at Annals of Oncology online) <ref type="bibr" target="#b268">[265]</ref>.</s><s>However, cerebral MRI might also be inconspicuous in allo-HSCT recipients with HSV encephalitis <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b73">73]</ref>.</s></p><p><s>HSV encephalitis should immediately be treated with aciclovir [AII t ] [73, <ref type="bibr" target="#b187">[185]</ref><ref type="bibr" target="#b188">[186]</ref><ref type="bibr" target="#b189">[187]</ref>.</s></p><p><s>In rare cases of aciclovir resistance, foscarnet may be administered [CIII] <ref type="bibr" target="#b192">[190]</ref>.</s><s>Patients with HSV encephalitis have a good overall prognosis, but a large proportion of patients (up to 70%) recover with neurological sequelae <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b189">187]</ref>.</s></p><p><s>cytomegalovirus.</s><s>CMV CNS disease is typically characterized by ventriculo-encephalitis, retinitis and polyradiculopathy <ref type="bibr" target="#b197">[195,</ref><ref type="bibr" target="#b269">266,</ref><ref type="bibr" target="#b270">267]</ref>.</s><s>CSF CMV PCR has a high sensitivity (up to 100%) for the diagnosis of CMV CNS disease [A] <ref type="bibr" target="#b69">[69]</ref><ref type="bibr" target="#b70">[70]</ref><ref type="bibr" target="#b71">[71]</ref><ref type="bibr" target="#b72">[72]</ref>.</s><s>Detection of CMV in CSF by viral cultures might only be used as an adjunctive test since it has a low sensitivity of ∼20% [C] <ref type="bibr" target="#b69">[69,</ref><ref type="bibr" target="#b72">72]</ref>.</s></p><p><s>CMV CNS disease is commonly treated with ganciclovir or foscarnet [AIII] <ref type="bibr" target="#b190">[188]</ref>.</s><s>Some authors recommend a combination of both agents [BIII] <ref type="bibr" target="#b190">[188,</ref><ref type="bibr" target="#b197">[195]</ref><ref type="bibr" target="#b198">[196]</ref><ref type="bibr" target="#b199">[197]</ref>. Cidofovir as single agent or in combination with foscarnet or ganciclovir might be used for salvage treatment [CIII] <ref type="bibr" target="#b197">[195,</ref><ref type="bibr" target="#b202">200,</ref><ref type="bibr" target="#b203">201]</ref>.</s><s>Some reports support the use of leflunomide to control CMV disease [CIII] <ref type="bibr" target="#b203">[201,</ref><ref type="bibr" target="#b271">268,</ref><ref type="bibr" target="#b272">269]</ref>.</s><s>There are no systematic data showing a benefit of the routine administration of CMV hyperimmunoglobulin in patients with hematological disorders and CMV disease.</s></p><p><s>Epstein-Barr virus.</s><s>Except for patients with allo-HSCT, EBV disease other than infectious mononucleosis is a rare entity.</s><s>Diagnosis of EBV meningoencephalitis is based on CSF PCR [A] <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b73">[73]</ref><ref type="bibr" target="#b74">[74]</ref><ref type="bibr" target="#b75">[75]</ref>.</s><s>However, brain-biopsy-proven EBV meningoencephalitis in conjunction with a negative CSF EBV PCR has been reported <ref type="bibr" target="#b76">[76]</ref>.</s></p><p><s>A reduction of immunosuppression should be attempted whenever possible in patients with EBV disease or infection [AIII] <ref type="bibr" target="#b190">[188]</ref>.</s><s>The role of rituximab in EBV disease (i.e.</s><s>presence of EBV organ involvement) remains to be elucidated despite the fact that first experiences suggest that pre-emptive treatment of EBV infections (i.e.</s><s>EBV reactivation only) might reduce the incidence of post-transplant lymphoproliferative disorder <ref type="bibr" target="#b273">[270]</ref>.</s><s>Likewise, it remains unclear whether antivirals are beneficial in EBV disease <ref type="bibr" target="#b190">[188]</ref>.</s><s>Ganciclovir, valganciclovir or foscarnet might be used to treat EBV meningoencephalitis [BIII] and there are few case reports on the potential efficacy of aciclovir in this situation [CIII] <ref type="bibr" target="#b190">[188,</ref><ref type="bibr" target="#b204">[202]</ref><ref type="bibr" target="#b205">[203]</ref><ref type="bibr" target="#b206">[204]</ref><ref type="bibr" target="#b207">[205]</ref><ref type="bibr" target="#b208">[206]</ref><ref type="bibr" target="#b209">[207]</ref><ref type="bibr" target="#b210">[208]</ref><ref type="bibr" target="#b211">[209]</ref>.</s></p><p><s>human herpes virus-6.</s><s>HHV-6 CNS disease (mainly encephalitis) has rarely been described except in allo-HSCT recipients <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b77">77,</ref><ref type="bibr" target="#b78">78,</ref><ref type="bibr" target="#b212">210]</ref>.</s><s>HHV-6 encephalitis typically  <ref type="bibr" target="#b80">[80]</ref><ref type="bibr" target="#b82">[81]</ref><ref type="bibr" target="#b83">[82]</ref>.</s><s>The CSF VZV viral load determined by PCR might correlate with the severity and the duration of VZV meningoencephalitis <ref type="bibr" target="#b221">[218]</ref>.</s><s>Diagnosis of VZV meningoencephalitis may be confirmed by serological tests such as detection of intrathecal VZV glycoprotein E <ref type="bibr" target="#b275">[272]</ref>.</s><s>Rash and CSF pleocytosis might be absent in patients with cerebral VZV vasculopathy (such as strokes).</s><s>In this situation, detection of CSF anti-VZV IgG antibodies might have a higher sensitivity than CSF VZV PCR [B] <ref type="bibr" target="#b84">[83]</ref>.</s></p><p><s>VZV CNS infections can be successfully treated with aciclovir [AIII] <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b73">73,</ref><ref type="bibr" target="#b221">218]</ref>.</s><s>However, aciclovir resistance could occur and there are case reports on fatal CNS meningoencephalitis in allo-HSCT recipients despite early therapy with high-dose aciclovir <ref type="bibr" target="#b219">[216]</ref>.</s><s>These patients might benefit from a combination of aciclovir and foscarnet [CIII] <ref type="bibr" target="#b222">[219]</ref>.</s></p><p><s>JC virus.</s><s>JC virus-related PML typically affects severely immunocompromised hosts such as Acquired Immune Deficiency Syndrome (AIDS) patients or allo-HSCT recipients <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b276">273]</ref>.</s><s>CNS biopsy of suspicious lesions is required for definitive diagnosis of PML [A].</s><s>The typical triad (demyelination, bizarre astrocytes and enlarged oligodendroglial nuclei) can frequently be demonstrated by histopathological work-up in biopsies which might be combined with tissue and CSF JC virus (dual qualitative-quantitative nested) PCR [A] <ref type="bibr" target="#b87">[86,</ref><ref type="bibr" target="#b89">88,</ref><ref type="bibr" target="#b90">89]</ref>.</s><s>MRI typically shows abnormalities in the posterior white matter without contrast enhancement (supplementary Figure <ref type="figure">S5</ref>, available at Annals of Oncology online) <ref type="bibr" target="#b277">[274]</ref>.</s><s>The diagnosis of PML could also be established without CNS biopsy in immunocompromised patients with typical clinical symptoms and characteristic findings by neuroimaging together with a positive CSF JC virus PCR [A] <ref type="bibr" target="#b87">[86]</ref>.</s></p><p><s>Immune reconstitution seems to be crucial for treatment of PML, as suggested by the observation that the incidence of PML could be markedly reduced in AIDS patients by the introduction of highly active antiretroviral therapy (HAART) <ref type="bibr" target="#b276">[273,</ref><ref type="bibr" target="#b278">275]</ref>.</s><s>However, PML might develop or worsen (in the case of preexisting PML) at the beginning of HAART (PML-immune reconstitution inflammatory syndrome, IRIS) <ref type="bibr" target="#b276">[273,</ref><ref type="bibr" target="#b278">275,</ref><ref type="bibr" target="#b279">276]</ref>.</s><s>PML-IRIS has also been described during withdrawal of agents which are associated with the occurrence of PML, such as natalizumab <ref type="bibr" target="#b280">[277]</ref>.</s></p><p><s>Immunosuppressives should be reduced in allo-HSCT recipients with PML whenever possible [AIII] <ref type="bibr" target="#b11">[12]</ref>.</s><s>Treatment with cidofovir may be beneficial in some patients with PML <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b281">278,</ref><ref type="bibr" target="#b282">279]</ref>.</s><s>In contrast, other allo-HSCT recipients as well as a larger series of 370 AIDS patients with PML did not improve after treatment with cidofovir [DII t,u ] <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b224">221]</ref>.</s><s>Several experimental approaches such as adoptive T-cell therapy or administration of interleukin-2, mefloquine or mirtazapine have been tested as a treatment option for PML <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b281">[278]</ref><ref type="bibr" target="#b282">[279]</ref><ref type="bibr" target="#b283">[280]</ref>.</s><s>Since none of them has clearly shown to be effective in larger series of patients they are recommended within experimental protocols only <ref type="bibr">[DIII]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>conclusions</head><p><s>Diagnosis of CNS infections remains a great challenge in patients with hematological disorders since symptoms might both be masked and be mimicked by other conditions such as metabolic disturbances or consequences from antineoplastic treatment.</s><s>Thus, awareness of this complication is crucial and any suspicion of a CNS infection should lead to timely and adequate diagnostics and treatment to improve the outcome in this population.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>pathogenesis</head><label></label><figDesc><div><p><s>See supplementary Material, available at Annals of Oncology online.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Diagnostic procedures and management in patients with hematological disorder and CNS infection.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s><ref type="bibr" target="#b2">[3]</ref>ength of recommendation (A) and quality of evidence (B)[3]</s></p></div></figDesc><table><row><cell>(A)</cell><cell></cell></row><row><cell>Grade</cell><cell>Strength of recommendation</cell></row><row><cell cols="2">Grade A AGIHO 'strongly' supports a recommendation for use</cell></row><row><cell cols="2">Grade B AGIHO 'moderately' supports a recommendation for use</cell></row><row><cell cols="2">Grade C AGIHO 'marginally' supports a recommendation for use</cell></row><row><cell cols="2">Grade D AGIHO 'supports' a recommendation 'against' use</cell></row><row><cell>(B)</cell><cell></cell></row><row><cell>Level</cell><cell>Quality of evidence</cell></row><row><cell>I</cell><cell>Evidence from at least one properly designed randomized, controlled trial</cell></row><row><cell>II*</cell><cell>Evidence from at least one well-designed clinical trial, without randomization; from cohort or case-controlled analytic studies (preferably from</cell></row><row><cell></cell><cell>&gt;1 center); from multiple time series; or from dramatic results of uncontrolled experiments</cell></row><row><cell></cell><cell>*: Added index</cell></row><row><cell></cell><cell>r: Meta-analysis or systematic review of randomized, controlled trials</cell></row><row><cell></cell><cell>t: Transferred evidence, that is, results from different patients' cohorts, or similar immune-status situation</cell></row><row><cell></cell><cell>h: Comparator group is a historical control</cell></row><row><cell></cell><cell>u: Uncontrolled trial</cell></row><row><cell></cell><cell>a: Published abstract (presented at an International Symposium or meeting)</cell></row><row><cell>III</cell><cell>Evidence from opinions of respected authorities, based on clinical experience, descriptive case studies</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head></head><label></label><figDesc><div><p><s>Candida spp., bacteria or more rarely Cryptococcus spp.(Figure1,Table2).</s><s>For these CNS infections, brain biopsy is required only in selected cases.</s><s>Focal lesions, typically caused by Toxoplasma or Aspergillus spp.</s><s>are commonly diagnosed by histopathology of suspicious lesions.</s><s>Histopathological work-up should be done using adequate staining methods such as Calcofluor white.</s><s>Routine parameters in the CSF are frequently nonspecifically altered in these patients.</s></p></div></figDesc><table><row><cell>diagnosis</cell></row><row><cell>Any suspicion of CNS infection should immediately trigger ad-</cell></row><row><cell>equate diagnostic procedures including neuroimaging, cerebro-</cell></row><row><cell>spinal fluid (CSF) examination and, in selected cases, biopsy of</cell></row><row><cell>focal lesions (Figure 1). CSF analyses including various methods</cell></row><row><cell>such as staining and microscopy, culturing, serological techniques</cell></row><row><cell>and PCR assays are crucial to diagnose meningoencephalitis</cell></row><row><cell>which is typically caused by viruses,</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc><div><p><s>and supplementary TableS1, available at Annals of Oncology online.</s></p></div></figDesc><table><row><cell></cell><cell>Clinical symptoms indicative of CNS infection</cell><cell></cell></row><row><cell></cell><cell>(e.g. paresis, fever, signs of meningitis)</cell><cell></cell></row><row><cell>Neuroimaging (MRI and/or</cell><cell></cell><cell></cell></row><row><cell>CT scan) showing focal,</cell><cell>Imaging of the neurocranium: MRI (if readily</cell><cell>Neuroimaging (MRI and/or</cell></row><row><cell>parenchymatous</cell><cell>available), otherwise CT scan (usually followed by</cell><cell>CT scan) showing no focal</cell></row><row><cell>abnormalities (e.g. brain</cell><cell>MRI as soon as possible)</cell><cell>abnormalities</cell></row><row><cell>abscess)</cell><cell></cell><cell></cell></row><row><cell></cell><cell>Criteria for sterotactic brain</cell><cell></cell></row><row><cell></cell><cell>biopsy/neurosurgical resection</cell><cell>Analysis of CSF including cell count,</cell></row><row><cell></cell><cell>of brain lesions not fulfilled*</cell><cell>cell differentiation, gram staining,</cell></row><row><cell></cell><cell></cell><cell>measurement of glucose, LDH and</cell></row><row><cell></cell><cell></cell><cell>protein concentration, cultures (e.g.</cell></row><row><cell></cell><cell></cell><cell>bacterial and fungal) and PCR</cell></row><row><cell></cell><cell>Might be considered in</cell><cell>analyses (e.g. herpes viruses</cell></row><row><cell></cell><cell>addition to stereotactic</cell><cell>detection) (specified in Table 2)</cell></row><row><cell></cell><cell>biopsy in selected cases</cell><cell></cell></row><row><cell>Empirical/preemptive treatment:</cell><cell></cell><cell></cell></row><row><cell cols="2">Imaging results and CSF analyses indicative of:</cell><cell></cell></row><row><cell cols="2">• Bacterial CNS infection (e.g. abscess and/or neutrophil</cell><cell></cell></row><row><cell cols="2">pleocytosis): 3 rd generation cephalosporin or meropenem +</cell><cell></cell></row><row><cell>ampicillin +/-vancomycin</cell><cell></cell><cell></cell></row><row><cell cols="2">• Fungal CNS infection (e.g. abscess or infarction): voriconazole</cell><cell></cell></row><row><cell cols="2">• Cerebral toxoplasmosis (e.g. ring enhancement): pyrimethamine</cell><cell></cell></row><row><cell>+ sulfadiazine</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>Recommendations to diagnose CNS infections in patients with hematological disorders</s></p></div></figDesc><table><row><cell>Intention</cell><cell>Intervention</cell><cell>SoR Comments</cell></row></table><note><p><s>C Might only be used as an adjunctive test (sensitivity ∼20%) [69, 72] To diagnose EBV meningoencephalitis PCR (CSF) A Might be false-negative in allo-HSCT recipients [2, 73-76] A Sensitivity 75%-100%, repetitive CSF analyses might be useful, might also be false-positive (e.g. in healthy individuals with JC virus viremia) [86, 88-90] Bacteria To identify pathogen and perform resistance testing Culture (CSF) A CSF culture yield might significantly be reduced in patients with delayed lumbar puncture (&gt;4 h) after initiation of antibiotic treatment [91-93] Culture (blood) A Positive in 50%-80% of patients, after initiation of antibiotic treatment in ∼20% [92, 94] SoR, strength of recommendation; ELISA, enzyme-linked immunosorbent assay; LAT, latex agglutination test; LDH, lactate dehydrogenase; LAMP, loop-mediated isothermal amplification; H&amp;E, hematoxylin and eosin; PAS, periodic acid-Schiff; EIA, enzyme immunoassay; LFA, lateral flow immunochromatographic assay.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Recommendations to treat CNS infections in patients with hematological disorders a</s></p></div></figDesc><table><row><cell>Causative agent</cell><cell>Intention</cell><cell>Intervention</cell><cell>SoR/QoE</cell><cell>Comments</cell><cell>References</cell></row><row><cell>Toxoplasma spp.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Toxoplasma spp.</cell><cell>Primary anti-infective</cell><cell>Pyrimethamine (orally, 100-200 mg load, then</cell><cell>AII t</cell><cell></cell><cell></cell></row><row><cell></cell><cell>treatment and</cell><cell>50 mg/day) + sulfadiazine (orally, 1 g q6h)</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>prevention of CNS</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>relapse</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>-to cure -</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Continued</s></p></div></figDesc><table><row><cell>Aspergillus spp.</cell><cell>Primary anti-infective</cell><cell>Voriconazole (i.v., 6 mg/kg q12h for the first</cell><cell>AII u</cell></row><row><cell></cell><cell>treatment b</cell><cell>24 h, then 4 mg/kg q12h)</cell><cell></cell></row><row><cell></cell><cell>-to cure -</cell><cell></cell><cell></cell></row></table><note><p><s>[171][172][173][122][123][124][125][126]unclear) or ABLC c (i.v., 5 mg/kg/day) BIII Reserved for rare cases (e.g.severe intolerance to voriconazole, resistant isolates), might in particular be useful if mucormycosis cannot be excluded[119][120][121][122][123][124][125][126]L-AmB (i.v., 3-4 mg/kg/day) or ABLC c (i.v., 5 mg/kg/day) + 5-FC (i.v., 25 mg/kg q6h) d AII t• Induction therapy for at least 4 weeks, might be followed by consolidation with fluconazole (400 mg/d) at least 8 weeks• Consider unfavorable toxicity profile of D-AmB[171][172][173]D-AmB (i.v., 0.7-1.0</s><s>mg/kg/day) + 5-FC (i.v.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head></head><label></label><figDesc><div><p><s>[150]ales, C. neoformans and Candida spp.may also be detected in these patients[150].Aspergillus spp.</s><s>Most commonly, CNS Aspergillosis results in brain abscess formation, but fungal embolism can also cause cerebral infarction with or without hemorrhage.</s><s>Rarely, CNS aspergillosis presents with overt meningitis or cause granuloma</s></p></div></figDesc><table><row><cell>[92, 226]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>[227, 228]</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Add vancomycin if a high rate of penicillin-resistant S.</cell><cell>pneumoniae strains is present</cell><cell></cell><cell></cell><cell></cell><cell>Carbapenem of choice for Enterobacteriaceae (more</cell><cell>potent than imipenem and ertapenem)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>AII t</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>BIII</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>To reduce mortality in Meropenem (2 g q8h) or ceftriaxone (2 g q12h)</cell><cell>first-line empirical or cefotaxime (8-12 g/day in 4-6 daily</cell><cell>treatment dosages) + ampicillin (2 g q4h) ±</cell><cell>vancomycin (30-60 mg/kg/day in 2-3 daily</cell><cell>dosages)</cell><cell>To reduce mortality Meropenem (2 g q8h)</cell><cell>(Gram-negative</cell><cell>strains)</cell><cell>The authors do not take any responsibility for dosages of antiinfectious agents.</cell><cell>. Besides neuroimaging, diagnosis of cerebral toxoplasmosis is based on demonstration of tachyzoites or cysts in the CSF [A], CSF PCR [B] and serological tests such as CSF enzyme-linked immunosorbent assay [C] [24, 25, 29]. Primary treatment of cerebral toxoplasmosis should comprise a combination of pyrimethamine and sulfadiazine [AII t ] [110]. Pyrimethamine in combination with clindamycin [BII t ] or single-agent trimethoprim-sulfamethoxazole [BII t ] may alter-natively be used [110, 111, 236]. Maintenance treatment should be conducted for at least 3 months [BIII]. Atovaquone could be administered in patients with intolerance/refractoriness to conventional antitoxoplasmic agents [BII t,u ] [115, 116]. fungi The predominant fungal pathogens causing CNS infections in</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>patients with hematological disorders are Aspergillus spp., with</cell></row></table><note><p><s>a For detailed recommendations on treatment of different bacterial CNS infections in patients with hematological disorders, see supplementary Material, available at Annals of Oncology online.</s><s>b Antifungal drug therapy should be continued for at least 4 weeks after resolution of all signs and symptoms of the infection.</s><s>c Not distributed in some countries (e.g.</s><s>Germany).</s><s>d Therapeutic drug monitoring recommended.</s><s>e Longer treatment periods might be advisable (e.g.</s><s>determined by repeated CSF analyses).</s><s>f Usual pediatric dose (immunocompromised host): 10-20 mg/kg q8h.</s><s>QoE, quality of evidence; ABLC, amphotericin B lipid complex.</s><s>Volume 27 | No. 7 | July 2016 doi:10.1093/annonc/mdw155</s><s>|  Annals of Oncology reviews A. fumigatus prevailing over other species such as A. nidulans, A. terreus and A. flavus [117].</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head></head><label></label><figDesc><div><p><s>[2,216,217] infection (chickenpox) occurs rarely in patients with hematological disorders, since VZV-seronegativity in adulthood is rare (∼5%).In VZVseropositive recipients, VZV disease after allo-HSCT most commonly manifests as dermatomal herpes zoster but a VZV meningoencephalitis may occur[2,216,217].Small patient series indicate that CSF PCR has a similar good sensitivity and specificity for diagnosis of VZV meningoencephalitis as for other herpes viruses[A]</s></p></div></figDesc><table><row><cell>Annals of Oncology</cell><cell>reviews</cell></row><row><cell>affects allo-HSCT recipients with unrelated (mainly cord blood)</cell><cell></cell></row><row><cell>donors and it frequently develops at the time of engraftment (or</cell><cell></cell></row><row><cell>shortly thereafter) [2, 7]. Common clinical symptoms include</cell><cell></cell></row><row><cell>alteration of consciousness, short-term memory loss and</cell><cell></cell></row><row><cell>seizures [2, 7, 271]. The diagnostic method of choice for</cell><cell></cell></row><row><cell>diagnosis of HHV-6 meningoencephalitis is quantitative CSF</cell><cell></cell></row><row><cell>PCR [A] [77, 78]. However, it should be noted that HHV-6</cell><cell></cell></row><row><cell>DNA might be detected in CSF in a significant proportion of</cell><cell></cell></row><row><cell>asymptomatic allo-HSCT recipients [79]. CSF analysis might</cell><cell></cell></row><row><cell>show elevated protein levels and, more rarely pleocytosis [2, 77].</cell><cell></cell></row><row><cell>Imaging abnormalities which typically involve the temporal</cell><cell></cell></row><row><cell>lobe are more likely visible in MRI than in CT scan</cell><cell></cell></row><row><cell>(supplementary Figure S4, available at Annals of Oncology</cell><cell></cell></row><row><cell>online) [2, 77]. Despite this, cerebral MRI might be normal in</cell><cell></cell></row><row><cell>the early phase of HHV-6 meningoencephalitis in allo-HSCT</cell><cell></cell></row><row><cell>recipients [2, 77, 78].</cell><cell></cell></row><row><cell>Ganciclovir or foscarnet could be used as first-line therapy for</cell><cell></cell></row><row><cell>HHV-6 meningoencephalitis [AIII] [7, 8, 210-213]. Cidofovir</cell><cell></cell></row><row><cell>can be administered as second-line treatment [CIII] [215].</cell><cell></cell></row><row><cell>varicella zoster virus.</cell><cell></cell></row></table><note><p><s>Volume 27 | No. 7 | July 2016 doi:10.1093/annonc/mdw155</s><s>| </s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_9"><head>acknowledgements</head><label></label><figDesc><div><p><s>The authors thank Martin Skalej and Anja Lenz (Institute of Neuroradiology, Otto-von-Guericke University Hospital Magdeburg, Magdeburg, Germany) and Hans-Christian Bauknecht for providing MRI images (see supplementary Material, available at Annals of Oncology online).</s><s>funding None.</s><s>Travel expenses and costs for group meetings were reimbursed by the German Society for Hematology and Medical Oncology (DGHO).</s><s>disclosure GS: grant/research support: MSD Sharp &amp; Dohme, Pfizer, Gilead Sciences, Astellas Pharma; consultant: MSD Sharp &amp; Dohme, Basilea Pharmaceutica.</s><s>WH: research grants: MSD Sharp &amp; Dohme, Merck, Pfizer; speakers bureaus: Alexion Pharmaceuticals, Astellas Pharma, Basilea Pharmaceutica, Bristol-Myers Squibb, Chugai Pharmaceutical, Gilead Sciences, Janssen-Cilag, MSD Sharp &amp; Dohme, Pfizer; travel grants: Alexion Pharmaceuticals, Astellas Pharma, MSD Sharp &amp; Dohme, Novartis Pharma, Pfizer.</s><s>JP: honoraria, travel support, advisory board: MSD Sharp &amp; Dohme, Gilead Sciences, Pfizer, Astellas Pharma.</s><s>OP: research funding: Neovii Biotech, Jazz Pharmaceuticals, Takeda Pharma, Sanofi, Pierre Fabre; consultant: MSD Sharp &amp; Dohme, Alexion Pharmaceuticals, Jazz; lecture honoraria/travel grants: Astellas Pharma, Gilead Sciences, Pfizer, MSD Sharp &amp; Dohme.</s><s>MC: speaker's bureau: Basilea Pharmaceutica, MSD Sharp &amp; Dohme; advisory board: Basilea Pharmaceutica, MSD Sharp &amp; Dohme; congress support: Gilead Sciences, MSD Sharp &amp; Dohme, Neovii Biotech, Takeda Pharma, Celgene.</s><s>DB: speaker's bureau: Astellas Pharma, Gilead Sciences, Merck, MSD Sharp &amp; Dohme, Pfizer; research grants: Gilead Sciences, Pfizer; travel grants: Astellas Pharma, Merck, MSD Sharp &amp; Dohme, Pfizer; consultant: Basilea Pharmaceutica, Gilead Sciences.</s><s>MR: advisory board: Basilea Pharmaceutica, Janssen-Cilag.</s><s>SS: honoraria, advisory board, travel grants: MSD Sharp &amp; Dohme, Pfizer, Gilead Sciences, Astellas Pharma.</s><s>GM: consultations: Gilead Sciences; sponsored research: Pfizer; honoraria: Astellas Pharma, Gilead Sciences, MSD Sharp &amp; Dohme, Pfizer.</s><s>All remaining authors have declared no conflicts of interest.</s></p></div></figDesc><table><row><cell>references</cell></row></table></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Spectrum and prognosis of neurologic complications after hematopoietic transplantation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Denier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bourhis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lacroix</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1990" to="1997" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents</title>
		<author>
			<persName><forename type="first">M</forename><surname>Schmidt-Hieber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schwender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Heinz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="142" to="149" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">ESCMID guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Ullmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Cornely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Donnelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Bleggi-Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>De Medeiros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Werner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="301" to="307" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Prospective evaluation of neurological complications after allogeneic bone marrow transplantation</title>
		<author>
			<persName><forename type="first">P</forename><surname>Sostak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Padovan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Yousry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="842" to="848" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Opportunistic CNS infection after bone marrow transplantation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Maschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Dietrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Prumbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1167" to="1176" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation</title>
		<author>
			<persName><forename type="first">T</forename><surname>Vu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Carrum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hutton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="705" to="709" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<author>
			<persName><forename type="first">A</forename><surname>Skiada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lanternier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Groll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia</title>
				<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="492" to="504" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Epidemiology and outcome of zygomycosis: a review of 929 reported cases</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Roden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Zaoutis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Buchanan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="634" to="653" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between</title>
		<author>
			<persName><forename type="first">A</forename><surname>Skiada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pagano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Groll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1859" to="1867" />
			<date type="published" when="2005">2005 and 2007. 2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Carson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Evens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Richey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="4834" to="4840" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Kharfan-Dabaja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ayala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Greene</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="101" to="107" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Meningitis in pediatric cancer patients: a review of forty cases from a single institution</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Sommers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Hawkins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Infect Dis J</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="902" to="907" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Bacterial and fungal meningitis in patients with cancer</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Safdieh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Mead</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Sepkowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="943" to="947" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Clinical review: efficacy of antimicrobial-impregnated catheters in external ventricular drainage-a systematic review and metaanalysis</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Qi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">234</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)</title>
		<author>
			<persName><forename type="first">S</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Krause</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Maschmeyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Hematol</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="433" to="442" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology</title>
		<author>
			<persName><forename type="first">D</forename><surname>Tacke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Buchheidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Karthaus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Hematol</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1449" to="1456" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Central nervous system infections in cancer patients</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Pruitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Neurol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="296" to="310" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Central nervous system infections in the compromised host: a diagnostic approach</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Cunha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Dis Clin North Am</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="567" to="590" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the downregulated expression of inducible nitric oxide synthase and other markers of macrophage activation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Gazzinelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Eltoum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Wynn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3672" to="3681" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Groll</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transpl Infect Dis</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="247" to="261" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Diagnosis and management of central nervous system histoplasmosis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Wheat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Musial</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jenny-Avital</forename></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="844" to="852" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Central nervous system tuberculosis: pathogenesis and clinical aspects</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Rock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Olin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Baker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Rev</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="243" to="261" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Montoya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S73" to="S82" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">The utility of cerebrospinal fluid for the molecular diagnosis of toxoplasmic encephalitis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Mikita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Maeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ono</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagn Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="155" to="159" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Vidal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Colombo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>De Oliveira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4765" to="4768" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Conventional polymerase chain reaction for the diagnosis of neurotoxoplasmosis: comparison of three sets of primers for the B1 gene using CSF samples</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Alfonso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fraga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cox</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagn Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="150" to="154" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Usefulness and limitations of polymerase chain reaction in the etiologic diagnosis of neurotoxoplasmosis in immunocompromised patients</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Anselmo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Vilar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Lima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">346</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="231" to="234" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Diagnosis of neurotoxoplasmosis by antibody detection in cerebrospinal (CSF) fluid using Latex Agglutination Test and ELISA</title>
		<author>
			<persName><forename type="first">A</forename><surname>Chandramukhi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Commun Dis</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="153" to="158" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">In situ hybridization for the identification of filamentous fungi in tissue section</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Hayden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Procop</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagn Mol Pathol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="119" to="126" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Pathology of fungal infections of the central nervous system: 17 years&apos; experience from Southern India</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sundaram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Umabala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Laxmi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histopathology</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="396" to="405" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases</title>
		<author>
			<persName><forename type="first">S</forename><surname>Antinori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Corbellino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Meroni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="218" to="238" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Verweij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Brinkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">P</forename><surname>Kremer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1186" to="1189" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Viscoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Machetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gazzola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1496" to="1499" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Soeffker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wichmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Loderstaedt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog Transplant</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="71" to="74" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title/>
		<idno type="DOI">10.1093/annonc/mdw155|</idno>
		<imprint>
			<date type="published" when="2016-07">July 2016</date>
			<biblScope unit="volume">27</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Utility of Aspergillus antigen detection in specimens other than serum specimens</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Klont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Mennink-Kersten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Verweij</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1467" to="1474" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Reinwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Buchheidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hummel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e56706</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Assessment of a real-time PCR method to detect human non-cryptococcal fungal meningitis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Badiee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Alborzi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Iran Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="381" to="384" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Early diagnosis of central nervous system aspergillosis using polymerase chain reaction, latex agglutination test, and enzyme-linked immunosorbent assay</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ogawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kanda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="536" to="537" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Molecular diagnosis of cerebral aspergillosis by sequence analysis with panfungal polymerase chain reaction</title>
		<author>
			<persName><forename type="first">H</forename><surname>Komatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Inui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Hematol Oncol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="40" to="44" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Spiess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kentouche</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="3989" to="3993" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">)-β-D-Glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mikulska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Furfaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Del</forename><surname>Bono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">1-3</biblScope>
			<biblScope unit="page" from="1511" to="1512" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">1→3)-β-D-Glucan in cerebrospinal fluid as a biomarker for Candida and aspergillus infections of the central nervous system in pediatric patients</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Salvatore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Toussi</surname></persName>
		</author>
		<idno type="DOI">10.1093/jpids/piv014</idno>
	</analytic>
	<monogr>
		<title level="j">J Pediatric Infect Dis Soc</title>
		<imprint>
			<date type="published" when="2015-03-19">2015. March 19</date>
		</imprint>
	</monogr>
	<note>epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">The central nervous system and infection by Candida species</title>
		<author>
			<persName><forename type="first">J</forename><surname>Sánchez-Portocarrero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pérez-Cecilia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Corral</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagn Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="169" to="179" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Chronic candidal meningitis: an uncommon manifestation of candidiasis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Voice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Bradley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sangeorzan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Kauffman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="60" to="66" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Detection of the Candida antigen mannan in cerebrospinal fluid specimens from patients suspected of having Candida meningitis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Verduyn Lunel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Voss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Kuijper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="867" to="870" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Culture-negative Candida meningitis diagnosed by detection of Candida mannan antigen in CSF</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Biesbroek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Verduyn</forename><surname>Lunel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Kragt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="1555" to="1556" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Cerebral granuloma and meningitis caused by Candida albicans: useful monitoring of mannan antigen in cerebrospinal fluid</title>
		<author>
			<persName><forename type="first">K</forename><surname>Ikeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yamashita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fujisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fujita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosurgery</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="860" to="863" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Cerebrospinal fluid (1,3)-β-D-glucan in isolated Candida meningitis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Lyons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Erkkinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Vodopivec</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="161" to="162" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Chronic meningitis caused by Candida albicans in a liver transplant recipient: usefulness of the polymerase chain reaction for diagnosis and for monitoring treatment</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Ralph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Hussain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="191" to="192" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Evaluation of the Candigen enzyme-linked immunosorbent assay for quantitative detection of Candida species antigen</title>
		<author>
			<persName><forename type="first">S</forename><surname>Elsayed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fitzgerald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Massey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Hussain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Pathol Lab Med</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="344" to="346" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Molecular detection and identification of Candida and Aspergillus spp. from clinical samples using real-time PCR</title>
		<author>
			<persName><forename type="first">L</forename><surname>Klingspor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jalal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="745" to="753" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Zygomycosis: conventional laboratory diagnosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lass-Flörl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="60" to="65" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples</title>
		<author>
			<persName><forename type="first">V</forename><surname>Rickerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Just-Nübling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Konrad</forename><forename type="middle">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="8" to="13" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Molecular methods to improve diagnosis and identification of mucormycosis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Hammond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bialek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Milner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2151" to="2153" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Future directions in mucormycosis research</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Kontoyiannis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Lortholary</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S79" to="S85" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients</title>
		<author>
			<persName><forename type="first">L</forename><surname>Millon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Larosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Lepiller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="e95" to="101" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Detection of Cryptococcus by conventional, serological and molecular methods</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Saha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Xess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Biswas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Microbiol</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="1098" to="1105" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>Pt 8</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Comparison of real-time florescence quantitative PCR measurements of VAD1 mRNA with three conventional methods in diagnosis and follow-up treatment of Cryptococcus neoformans infection</title>
		<author>
			<persName><forename type="first">O</forename><surname>Qishui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="326" to="332" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">New approaches to the diagnosis and treatment of cryptococcal meningitis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Makadzange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mchugh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Neurol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="47" to="60" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Neurocryptococcosis: diagnosis by PCR method</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Paschoal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Hirata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Hirata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Inst Med Trop Sao Paulo</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="203" to="207" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Cryptococcal meningitis in Senegal: epidemiology, laboratory findings, therapeutic and outcome of cases diagnosed from</title>
		<author>
			<persName><forename type="first">D</forename><surname>Sow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Tine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sylla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycopathologia</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="issue">5-6</biblScope>
			<biblScope unit="page" from="443" to="449" />
			<date type="published" when="2004">2004 to 2011. 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Evaluation of a new cryptococcal antigen lateral flow immunoassay in serum, cerebrospinal fluid and urine for the diagnosis of cryptococcosis: a meta-analysis and systematic review</title>
		<author>
			<persName><forename type="first">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rajbanshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e0127117</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid</title>
		<author>
			<persName><forename type="first">E</forename><surname>Aurelius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Johansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sköldenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">337</biblScope>
			<biblScope unit="issue">8735</biblScope>
			<biblScope unit="page" from="189" to="192" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Lakeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Whitley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="857" to="863" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Whitley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lakeman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="414" to="420" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Detection of antigen to herpes simplex virus in cerebrospinal fluid from patients with herpes simplex encephalitis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">D</forename><surname>Lakeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Koga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Whitley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1172" to="1178" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">HSV IgG antibody inhibits virus detection in CSF</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Fening</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Esper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Scholl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">T</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="164" to="167" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Diagnosis of herpesvirus infections of the central nervous system</title>
		<author>
			<persName><forename type="first">G</forename><surname>Boivin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Herpes</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="48A" to="56A" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Arribas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Clifford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Fichtenbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="527" to="531" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Cytomegalovirus encephalitis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Arribas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Storch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Clifford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Tselis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="577" to="587" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Detection of human cytomegalovirus pp67 late gene transcripts in cerebrospinal fluid of human immunodeficiency virus type 1-infected patients by nucleic acid sequence-based amplification</title>
		<author>
			<persName><forename type="first">F</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tetali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">P</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1920" to="1925" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Herpesvirus-associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">e77805</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Comparison of nested PCR and real time PCR of Herpesvirus infections of central nervous system in HIV patients</title>
		<author>
			<persName><forename type="first">L</forename><surname>Drago</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lombardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>De Vecchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Infect Dis</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">55</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Diagnosis of neurological herpesvirus infections: real time PCR in cerebral spinal fluid analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gaeta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Verzaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Cristina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">New Microbiol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="333" to="340" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Proven Epstein-Barr encephalitis with negative EBV-DNA load in cerebrospinal fluid after allogeneic hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia</title>
		<author>
			<persName><forename type="first">W</forename><surname>Barberi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Perrone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Iori</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Transplant</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="E19" to="E24" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Zerr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S52" to="S56" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Bhanushali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Kranick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Freeman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="1494" to="1500" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Human herpesvirus 6 can be detected in cerebrospinal fluid without associated symptoms after allogeneic hematopoietic cell transplantation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Boeckh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Sedlak</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="289" to="292" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<monogr>
		<title level="m" type="main">Detection of varicellazoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of  | Schmidt</title>
		<author>
			<persName><forename type="first">E</forename><surname>Puchhammer-Stöckl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Popow-Kraupp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">X</forename><surname>Heinz</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016-07">July 2016</date>
			<biblScope unit="volume">27</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">patients suffering from neurological complications associated with chicken pox or herpes zoster</title>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1513" to="1516" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations</title>
		<author>
			<persName><forename type="first">T</forename><surname>Bergström</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Infect Dis Suppl</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="41" to="45" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients: changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid</title>
		<author>
			<persName><forename type="first">I</forename><surname>Corral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Quereda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Antela</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurovirol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="129" to="135" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Nagel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Forghani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mahalingam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1069" to="1073" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Varicella zoster virus and central nervous system syndromes</title>
		<author>
			<persName><forename type="first">D</forename><surname>Gilden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Herpes</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="89A" to="94A" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Nagel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Cohrs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mahalingam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="853" to="860" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Aksamit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Clifford</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="1430" to="1438" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mcguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Barhite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hollander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miles</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="395" to="399" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Koralnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Boden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">X</forename><surname>Mai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="253" to="260" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy</title>
		<author>
			<persName><forename type="first">A</forename><surname>De Luca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cingolani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Linzalone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1343" to="1346" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Marzocchetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Giambenedetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cingolani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="4175" to="4177" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy. Part III of a three-part series</title>
		<author>
			<persName><forename type="first">V</forename><surname>Bohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hansen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="193" to="202" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Brouwer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Tunkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Van De Beek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Rev</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="467" to="492" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Effect of delayed lumbar punctures on the diagnosis of acute bacterial meningitis in adults</title>
		<author>
			<persName><forename type="first">B</forename><surname>Michael</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Menezes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cunniffe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Med J</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="433" to="438" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Nigrovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Malley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Macias</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="726" to="730" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Bacterial meningitis: rapid diagnosis and microbial profile: a multicentered study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shameem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vinod</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Neelagund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Commun Dis</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="111" to="120" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Thwaites</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Chau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stepniewska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="issue">9342</biblScope>
			<biblScope unit="page" from="1287" to="1292" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Attenuated cerebrospinal fluid leukocyte count and sepsis in adults with pneumococcal meningitis: a prospective cohort study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Weisfelt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Van De Beek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Spanjaard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Infect Dis</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">149</biblScope>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and metaanalysis</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">T</forename><surname>Huy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">T</forename><surname>Thao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Diep</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">R240</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Simultaneous singletube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae</title>
		<author>
			<persName><forename type="first">G</forename><surname>Tzanakaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsopanomichalou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kesanopoulos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="386" to="390" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Eight-plex PCR and liquid-array detection of bacterial and viral pathogens in cerebrospinal fluid from patients with suspected meningitis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Bøving</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Pedersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Møller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="908" to="913" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Meningitis caused by Neisseria Meningitidis, Hemophilus Influenzae Type B and Streptococcus Pneumoniae during 2005-2012 in Turkey. A multicenter prospective surveillance study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ceyhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gürler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ozsurekci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Vaccin Immunother</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2706" to="2712" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Analysis of the utility of diffusionweighted MRI and apparent diffusion coefficient values in distinguishing central nervous system toxoplasmosis from lymphoma</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Schroeder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Post</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Oschatz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroradiology</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="715" to="720" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Neuropathology of viral infections of the central nervous system</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Shankar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mahadevan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Kovoor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroimaging Clin N Am</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="19" to="39" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Severe cerebral toxoplasma infection cannot be excluded by a normal CT scan</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Weenink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Weenink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Geerlings</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neth J Med</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="150" to="152" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Usefulness of stereotactic biopsy and neuroimaging in management of HIV-1 Clade C associated focal brain lesions with special focus on cerebral toxoplasmosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Shyam Babu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Satishchandra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mahadevan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Neurol Neurosurg</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="995" to="1002" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Clinical usefulness of FDG PET/CT in the detection of unusual central nervous system infections</title>
		<author>
			<persName><forename type="first">J</forename><surname>Tseng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">345</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="244" to="247" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Miner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Heegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mapes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Biros</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Emerg Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="387" to="392" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Chamilos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Kontoyiannis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="503" to="509" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Central nervous system infections in immunocompromised patients: update on diagnostics and therapy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Schmidt-Hieber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zweigner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Uharek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leuk Lymphoma</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="24" to="36" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS</title>
		<author>
			<persName><forename type="first">C</forename><surname>Katlama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>De Wit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Doherty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="268" to="275" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group</title>
		<author>
			<persName><forename type="first">B</forename><surname>Dannemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mccutchan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Israelski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="33" to="43" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">U</forename><surname>Foppa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gregis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="187" to="189" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS</title>
		<author>
			<persName><forename type="first">C</forename><surname>Katlama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="189" to="191" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Randomized trial of trimethoprimsulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group</title>
		<author>
			<persName><forename type="first">D</forename><surname>Torre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Casari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Speranza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1346" to="1349" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group</title>
		<author>
			<persName><forename type="first">C</forename><surname>Katlama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mouthon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gourdon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1107" to="1112" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039</title>
		<author>
			<persName><forename type="first">K</forename><surname>Chirgwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hafner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Leport</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1243" to="1250" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Improved outcome in central nervous system aspergillosis, using voriconazole treatment</title>
		<author>
			<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruhnke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ribaud</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2641" to="2645" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Reisman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Troke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infection</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="201" to="210" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgerycase report and review of the literature</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Coleman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Hogg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Rosenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Waters</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosurgery</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="858" to="863" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant</title>
		<author>
			<persName><forename type="first">A</forename><surname>Carlini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Angelini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Burrows</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transplant</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2659" to="2661" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gadong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kelsey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Hematol Oncol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="497" to="504" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<monogr>
		<title/>
		<idno type="DOI">10.1093/annonc/mdw155|</idno>
		<imprint>
			<date type="published" when="2016-07">July 2016</date>
			<biblScope unit="volume">27</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease</title>
		<author>
			<persName><forename type="first">V</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Selby</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="273" to="275" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Successful multimodal therapy of invasive pulmonary and central nervous system aspergillosis in a neutropenic surgical patient: case report and review of the literature</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kaffarnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Utzolino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Blaich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Hopt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="74" to="78" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemia</title>
		<author>
			<persName><forename type="first">U</forename><surname>Mahlknecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Von Lintig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mertelsmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Leuk Lymphoma</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="191" to="194" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Azole-resistant central nervous system aspergillosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Van Der Linden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Jansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bresters</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1111" to="1113" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Verweij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ananda-Rajah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Andes</surname></persName>
		</author>
		<idno>21-22: 30-40</idno>
	</analytic>
	<monogr>
		<title level="j">Drug Resist Updat</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Treatment of cerebral Aspergillosis with itraconazole: do high doses improve the prognosis?</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sánchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mauri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dalmau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1485" to="1487" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">High-dose itraconazole for the treatment of cerebral aspergillosis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Verweij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Donnelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Meis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1196" to="1197" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Central nervous system aspergillosis in an immunocompetent patient: cure in a hospice setting with very high-dose itraconazole</title>
		<author>
			<persName><forename type="first">A</forename><surname>Palanisamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fouts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kerr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hosp Palliat Care</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="139" to="144" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model</title>
		<author>
			<persName><forename type="first">J</forename><surname>Imai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fernandez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="166" to="171" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">A case of invasive central nervous system aspergillosis treated with micafungin with monitoring of micafungin concentrations in the cerebrospinal fluid</title>
		<author>
			<persName><forename type="first">S</forename><surname>Okugawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tatsuno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="344" to="346" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">Activity of posaconazole in the treatment of central nervous system fungal infections</title>
		<author>
			<persName><forename type="first">P</forename><surname>Pitisuttithum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Negroni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Graybill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="745" to="755" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Posaconazole responsive cerebral aspergillosis in an immunocompetent adult</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Ellenbogen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Waqar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Denning</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Neurosci</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1825" to="1827" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">Poor efficacy of amphotericin B-based therapy in CNS aspergillosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruhnke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ribaud</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="196" to="200" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Herbrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Denning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Patterson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">347</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="408" to="415" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">Improved survival in central nervous system aspergillosis: a series of immunocompromised children with leukemia undergoing stereotactic resection of aspergillomas</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Middelhof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Loudon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Muhonen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurosurg</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="374" to="378" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="report_type">Report</note>
	<note>of four cases. Suppl</note>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Preoperative antifungal therapy may improve survival in patients with Aspergillus brain abscess</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wasay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Azam</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Neurol Neurosurg</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="565" to="567" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Invasive intracranial aspergillosis: the management dilemmas</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mohindra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Mukherjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chhabra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Surg Neurol</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="496" to="505" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">Intracranial aspergilloma in immunocompetent patients successfully treated with radical surgical intervention and antifungal therapy: case series</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">S</forename><surname>Srinivasan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Acad Med Singap</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="783" to="787" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Liposomal amphotericin B treatment for neonatal fungal infections</title>
		<author>
			<persName><forename type="first">A</forename><surname>Scarcella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Pasquariello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Giugliano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Infect Dis J</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="146" to="148" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Candida infection of the central nervous system following neurosurgery: a 12-year review</title>
		<author>
			<persName><forename type="first">D</forename><surname>O'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">T</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Lim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neurochir (Wien)</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1347" to="1350" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">Candida albicans meningitis in a 27 weeks premature infant treated with liposomal amphotericin-B (AmBisome)</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Jarløv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Born</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bruun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="419" to="420" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Denning</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1093" to="1098" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">Treatment of Candida infections with amphotericin B lipid complex</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hooshmand-Rad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="S384" to="S391" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">Brain stem candidiasis mimicking cerebellopontine angle tumor</title>
		<author>
			<persName><forename type="first">X</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Lazareff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Surg Neurol</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="87" to="91" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Kullberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruhnke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">366</biblScope>
			<biblScope unit="issue">9495</biblScope>
			<biblScope unit="page" from="1435" to="1442" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Candidal meningitis in HIV-infected patients: analysis of 14 cases</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Casado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Quereda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Oliva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="673" to="676" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">Candida albicans meningitis: clinical case</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Aleixo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Caldeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Ferreira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="191" to="192" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">Clinical characteristics, treatment and prognostic factors of candidal meningitis in a teaching hospital in Taiwan</title>
		<author>
			<persName><forename type="first">T</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="124" to="130" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Management of intracranial fungal infections in patients with haematological malignancies</title>
		<author>
			<persName><forename type="first">G</forename><surname>Mattiuzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Giles</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="287" to="300" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Hope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mickiene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Petraitis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">197</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="163" to="171" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b154">
	<analytic>
		<title level="a" type="main">Refractory candidal meningitis in an immunocompromised patient cured by caspofungin</title>
		<author>
			<persName><forename type="first">K</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="5950" to="5953" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b155">
	<analytic>
		<title level="a" type="main">Efficacy of caspofungin in a juvenile mouse model of central nervous system candidiasis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Flattery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hickey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Gill</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3491" to="3497" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b156">
	<analytic>
		<title level="a" type="main">A global analysis of mucormycosis in France: the RetroZygo Study</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lanternier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dannaoui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Morizot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S35" to="S43" />
			<date type="published" when="2005">2005-2007. 2012</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b157">
	<analytic>
		<title level="a" type="main">Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pagano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Valentini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Posteraro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Chemother</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="322" to="329" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b158">
	<analytic>
		<title level="a" type="main">Forty-one recent cases of invasive zygomycosis from a global clinical registry</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Rüping</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Heinz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Kindo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="296" to="302" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b159">
	<analytic>
		<title level="a" type="main">Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Hiemenz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Seibel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1383" to="1396" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b160">
	<analytic>
		<title level="a" type="main">How I treat mucormycosis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Kontoyiannis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Lewis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1216" to="1224" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b161">
	<analytic>
		<title level="a" type="main">Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Reed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bryant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Ibrahim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="364" to="371" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b162">
	<analytic>
		<title level="a" type="main">A mucormycosis case treated with a combination of caspofungin and amphotericin B</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kazak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Aslan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Akalın</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mycol Med</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="179" to="184" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b163">
	<analytic>
		<title level="a" type="main">Combination therapy for mucormycosis: why, what, and how?</title>
		<author>
			<persName><forename type="first">B</forename><surname>Spellberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Roilides</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S73" to="S78" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b164">
	<analytic>
		<title level="a" type="main">Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Z</forename><surname>Abidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Sohail</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Cummins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="687" to="698" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b165">
	<analytic>
		<title level="a" type="main">Disseminated mucormycosis in a paediatric patient: lichthemia corymbifera successfully treated with combination antifungal therapy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Davis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Mycol Case Rep</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="18" to="21" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b166">
	<analytic>
		<title level="a" type="main">Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pagano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Cornely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Busca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="e127" to="e130" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b167">
	<analytic>
		<title level="a" type="main">Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia</title>
		<author>
			<persName><forename type="first">V</forename><surname>Rickerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Atta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Herrmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="27" to="30" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b168">
	<analytic>
		<title level="a" type="main">Posaconazole combined with amphotericin B, an effective therapy for a murine disseminated infection caused by Rhizopus oryzae</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Rodríguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Serena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mariné</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="3786" to="3788" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b169">
	<analytic>
		<title level="a" type="main">Posaconazole as salvage therapy for zygomycosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mullane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Van Burik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="126" to="133" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b170">
	<analytic>
		<title level="a" type="main">Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Van Burik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Hare</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Solomon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="e61" to="e65" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b171">
	<analytic>
		<title level="a" type="main">Successful isavuconazole salvage therapy in a patient with invasive mucormycosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ervens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ghannoum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Graf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infection</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="429" to="432" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b172">
	<analytic>
		<title level="a" type="main">Isavuconazole treatment of a patient with disseminated mucormycosis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Peixoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Gagne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Hammond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1016" to="1019" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b173">
	<analytic>
		<title level="a" type="main">Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Brouwer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rajanuwong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chierakul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="issue">9423</biblScope>
			<biblScope unit="page" from="1764" to="1767" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b174">
	<analytic>
		<title level="a" type="main">Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 update by the Infectious Diseases Society of America</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Perfect</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Dismukes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dromer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="291" to="322" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b175">
	<analytic>
		<title level="a" type="main">Combination antifungal therapy for cryptococcal meningitis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Day</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Chau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wolbers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1291" to="1302" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b176">
	<analytic>
		<title level="a" type="main">High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Bicanic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Meintjes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="123" to="130" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b177">
	<analytic>
		<title level="a" type="main">Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Loyse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Meintjes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="121" to="128" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b178">
	<analytic>
		<title level="a" type="main">Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Coker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Viviani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Gazzard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="829" to="835" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b179">
	<analytic>
		<title level="a" type="main">Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Hamill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>El-Sadr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="225" to="232" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b180">
	<analytic>
		<title level="a" type="main">Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Jadhav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bamba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Shinde</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Postgrad Med</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="71" to="75" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b181">
	<analytic>
		<title level="a" type="main">A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIVassociated cryptococcal meningitis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Pappas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chetchotisakd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Larsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1775" to="1783" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b182">
	<analytic>
		<title level="a" type="main">Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant</title>
		<author>
			<persName><forename type="first">R</forename><surname>Bandettini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Castagnola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Calvillo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Chemother</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="108" to="109" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b183">
	<analytic>
		<title level="a" type="main">Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Sharkey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Graybill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Johnson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="315" to="321" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b184">
	<analytic>
		<title level="a" type="main">Combination flucytosine and highdose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Nussbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Namarika</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="338" to="344" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b185">
	<analytic>
		<title level="a" type="main">Voriconazole treatment for less-common, emerging, or refractory fungal infections</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Perfect</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Marr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Walsh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1122" to="1131" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b186">
	<analytic>
		<title level="a" type="main">Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Pfaller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Messer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">N</forename><surname>Woosley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="2571" to="2581" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b187">
	<analytic>
		<title level="a" type="main">Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients</title>
		<author>
			<persName><forename type="first">B</forename><surname>Sköldenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Forsgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Alestig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">8405</biblScope>
			<biblScope unit="page" from="707" to="711" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b188">
	<analytic>
		<title level="a" type="main">Vidarabine versus acyclovir therapy in herpes simplex encephalitis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Whitley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Alford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Hirsch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">314</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="144" to="149" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b189">
	<analytic>
		<title level="a" type="main">Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients</title>
		<author>
			<persName><forename type="first">U</forename><surname>Sili</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="112" to="118" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b190">
	<analytic>
		<title level="a" type="main">The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Tunkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Glaser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Bloch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="303" to="327" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b191">
	<analytic>
		<title level="a" type="main">Herpes simplex virus-1 encephalitis: a review of current disease management with three case reports</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Skelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Burger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Adekola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antivir Chem Chemother</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="13" to="18" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b192">
	<analytic>
		<title level="a" type="main">Acyclovir resistance in herpes simplex encephalitis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Schulte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sauerbrei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hoffmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="830" to="833" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b193">
	<analytic>
		<title level="a" type="main">Use of oral valaciclovir in a 12-year-old boy with herpes simplex encephalitis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Peiris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hong Kong Med J</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="119" to="121" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b194">
	<analytic>
		<title level="a" type="main">Valacyclovir for herpes simplex encephalitis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Pouplin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Pouplin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Toi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="3624" to="3626" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b195">
	<analytic>
		<title level="a" type="main">Herpes simplex virus 2 meningitis: a retrospective cohort study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Mateen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Aksamit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurovirol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="166" to="171" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b196">
	<analytic>
		<title level="a" type="main">Herpes simplex virus encephalitis pharmacotherapy: alternative treatment options</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Posey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Cleary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Evans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Pharmacother</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">7-8</biblScope>
			<biblScope unit="page" from="1103" to="1104" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b197">
	<analytic>
		<title level="a" type="main">CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drugresistant CMV infection and protracted immunodeficiency</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Winston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Territo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Schiller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="979" to="984" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b198">
	<analytic>
		<title level="a" type="main">Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients</title>
		<author>
			<persName><forename type="first">E</forename><surname>Mylonakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Kallas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Fishman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1337" to="1341" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b199">
	<analytic>
		<title level="a" type="main">Is combination antiviral therapy for CMV superior to monotherapy?</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Drew</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="485" to="488" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b200">
	<analytic>
		<title level="a" type="main">Successful use of cidofovir in treating AIDS-related cytomegalovirus retinitis, encephalitis, and esophagitis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Blick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Garton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Hopkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lagravinese</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Acquir Immune Defic Syndr Hum Retrovirol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="84" to="85" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b201">
	<analytic>
		<title level="a" type="main">Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir</title>
		<author>
			<persName><forename type="first">M</forename><surname>Sadler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Morris-Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Gazzard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1293" to="1294" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b202">
	<analytic>
		<title level="a" type="main">Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Battiwalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Paplham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Almyroudis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transpl Infect Dis</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="28" to="32" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b203">
	<analytic>
		<title level="a" type="main">Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet</title>
		<author>
			<persName><forename type="first">P</forename><surname>Hubacek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Keslova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Formankova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Transplant</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="919" to="922" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b204">
	<analytic>
		<title level="a" type="main">Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient</title>
		<author>
			<persName><forename type="first">M</forename><surname>Khalil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Enzinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wallner-Blazek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurovirol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="574" to="578" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b205">
	<analytic>
		<title level="a" type="main">Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Dellemijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brandenburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Niesters</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="311" to="312" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b206">
	<analytic>
		<title level="a" type="main">Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bossolasco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">I</forename><surname>Falk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ponzoni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="e21" to="e25" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b207">
	<analytic>
		<title level="a" type="main">Intravenous ganciclovir consistently induces remission of persistent Epstein-Barr encephalitis in an HIV-1-infected patient</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Katramados</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sripathi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Brar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Mitsias</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="778" to="780" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b208">
	<analytic>
		<title level="a" type="main">Successful treatment of Epstein-Barr virus encephalitis in the setting of HIV-associated neurocognitive disorder: a diagnostic and therapeutic challenge</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Trevillyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Mahony</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mclean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Hoy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antivir Ther (Lond)</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="257" to="261" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b209">
	<analytic>
		<title level="a" type="main">Cerebral vasculitis and encephalitis due to Epstein-Barr virus in a patient with newly diagnosed HIV infection</title>
		<author>
			<persName><forename type="first">L</forename><surname>Raman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nelson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Virol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="264" to="267" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b210">
	<analytic>
		<title level="a" type="main">Epstein-Barr virus infections of the central nervous system</title>
		<author>
			<persName><forename type="first">H</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Asaoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Imaizumi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intern Med</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="33" to="40" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b211">
	<analytic>
		<title level="a" type="main">Successful outcome of Epstein-Barr virus encephalitis managed with bilateral craniectomy, corticosteroids and aciclovir</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hayton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wakerley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Bowler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pract Neurol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="234" to="237" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b212">
	<analytic>
		<title level="a" type="main">Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ogata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Satou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kadota</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="671" to="681" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b213">
	<analytic>
		<title level="a" type="main">Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus</title>
		<author>
			<persName><forename type="first">N</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Paterson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transplantation</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2474" to="2479" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b214">
	<monogr>
		<title/>
		<idno type="DOI">10.1093/annonc/mdw155|</idno>
		<imprint>
			<date type="published" when="2016-07">July 2016</date>
			<biblScope unit="volume">27</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b215">
	<analytic>
		<title level="a" type="main">Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system</title>
		<author>
			<persName><forename type="first">S</forename><surname>Dewhurst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Herpes</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="105A" to="111A" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b216">
	<analytic>
		<title level="a" type="main">Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Seeley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Marty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Holmes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="156" to="165" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b217">
	<analytic>
		<title level="a" type="main">Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Zerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="309" to="317" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b218">
	<analytic>
		<title level="a" type="main">Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient</title>
		<author>
			<persName><forename type="first">C</forename><surname>Pöhlmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schetelig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Reuner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="e118" to="e120" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b219">
	<analytic>
		<title level="a" type="main">Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hackanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zeiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Bley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Transplant</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="566" to="570" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b220">
	<analytic>
		<title level="a" type="main">Varicella zoster virus meningoencephalitis after allogeneic hematopoietic stem cell transplantation</title>
		<author>
			<persName><forename type="first">J</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ashizawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Okuda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transpl Infect Dis</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="E7" to="E12" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b221">
	<analytic>
		<title level="a" type="main">Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rottenstreich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">K</forename><surname>Oz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Oren</forename><forename type="middle">I</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagn Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="174" to="177" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b222">
	<analytic>
		<title level="a" type="main">Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tauro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Toh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Osman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mahendra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="795" to="796" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b223">
	<analytic>
		<title level="a" type="main">Successful treatment of varicella zoster virus meningoencephalitis in patients with AIDS: report of four cases and review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Poscher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1115" to="1117" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b224">
	<analytic>
		<title level="a" type="main">Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>De Luca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ammassari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pezzotti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page" from="1759" to="1767" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b225">
	<analytic>
		<title level="a" type="main">Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors</title>
		<author>
			<persName><forename type="first">C</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Neurol Neurosurg</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="352" to="358" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b226">
	<analytic>
		<title level="a" type="main">Community-acquired bacterial meningitis in adults: antibiotic timing in disease course and outcome</title>
		<author>
			<persName><forename type="first">D</forename><surname>Lepur</surname></persName>
		</author>
		<author>
			<persName><surname>Barsic´b</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infection</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="225" to="231" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b227">
	<analytic>
		<title level="a" type="main">Advances in treatment of bacterial meningitis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Van De Beek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Brouwer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Thwaites</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Tunkel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="issue">9854</biblScope>
			<biblScope unit="page" from="1693" to="1702" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b228">
	<analytic>
		<title level="a" type="main">Corticosteroids for acute bacterial meningitis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Brouwer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mcintyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Van De Beek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">D004405</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b229">
	<analytic>
		<title level="a" type="main">A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group</title>
		<author>
			<persName><forename type="first">E</forename><surname>Schmutzhard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vukmirovits</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="85" to="97" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
	<note>Suppl A</note>
</biblStruct>

<biblStruct xml:id="b230">
	<analytic>
		<title level="a" type="main">Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Rhomberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Jones</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagn Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="414" to="426" />
			<date type="published" when="1999">1999-2008. 2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b231">
	<analytic>
		<title level="a" type="main">Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">Y</forename><surname>Lauderdale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">e0121668</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b232">
	<analytic>
		<title level="a" type="main">The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1080" to="1087" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b233">
	<analytic>
		<title level="a" type="main">Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mousset</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Buchheidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Heinz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Hematol</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="13" to="32" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b234">
	<analytic>
		<title level="a" type="main">Variability of voriconazole trough levels in haematological patients: influence of co-medications with CYP inhibitors and/or with CYP inhibitors plus CYP inducers</title>
		<author>
			<persName><forename type="first">P</forename><surname>Cojutti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Candoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Forghieri</surname></persName>
		</author>
		<idno type="DOI">10.1111/bcpt.12530</idno>
	</analytic>
	<monogr>
		<title level="j">Basic Clin Pharmacol Toxicol</title>
		<imprint>
			<date type="published" when="2015-11-17">2015 Nov 17</date>
		</imprint>
	</monogr>
	<note>epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b235">
	<analytic>
		<title level="a" type="main">Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients-an evidence-based approach</title>
		<author>
			<persName><forename type="first">M</forename><surname>Karthaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lehrnbecher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lipp</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Hematol</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="547" to="556" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b236">
	<analytic>
		<title level="a" type="main">Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Kublin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Zunt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="115" to="125" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b237">
	<analytic>
		<title level="a" type="main">Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience</title>
		<author>
			<persName><forename type="first">E</forename><surname>Roemer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">W</forename><surname>Blau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Basara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="E1" to="E8" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b238">
	<analytic>
		<title level="a" type="main">Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature</title>
		<author>
			<persName><forename type="first">C</forename><surname>Mueller-Mang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Mang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kalhs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Thurnher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroradiology</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="84" to="89" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b239">
	<analytic>
		<title level="a" type="main">An open study of the pyrimethamineclindamycin combination in AIDS patients with brain toxoplasmosis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Leport</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bastuji-Garin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Perronne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="557" to="558" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b240">
	<analytic>
		<title level="a" type="main">Aspergillus sinusitis and cerebral aspergillosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ruhnke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Aspergillus Fumigatus and Aspergillosis</title>
				<editor>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Latgé</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Steinbac</surname></persName>
		</editor>
		<meeting><address><addrLine>Washington, DC</addrLine></address></meeting>
		<imprint>
			<publisher>ASM Press</publisher>
			<date type="published" when="2008">2008</date>
			<biblScope unit="page" from="301" to="317" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b241">
	<analytic>
		<title level="a" type="main">Diffusion-weighted imaging in brain aspergillosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Charlot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pialat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Obadia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Neurol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="912" to="916" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b242">
	<analytic>
		<title level="a" type="main">Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients</title>
		<author>
			<persName><forename type="first">A</forename><surname>Gabelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kern</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Neurol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="548" to="555" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b243">
	<analytic>
		<title level="a" type="main">Quantification of brain voriconazole levels in healthy adults using fluorine magnetic resonance spectroscopy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Bolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Zuo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="5271" to="5276" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b244">
	<analytic>
		<title level="a" type="main">Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Clemons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Parmar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Stevens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="466" to="469" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b245">
	<analytic>
		<title level="a" type="main">Cerebral aspergillosis: tissue penetration is the key</title>
		<author>
			<persName><forename type="first">S</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Thiel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Mycol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S387" to="S393" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b246">
	<analytic>
		<title level="a" type="main">Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review</title>
		<author>
			<persName><forename type="first">M</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Wald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tzakis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Infect Dis</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="653" to="657" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b247">
	<analytic>
		<title level="a" type="main">Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemia</title>
		<author>
			<persName><forename type="first">V</forename><surname>Buxhofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ruckser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Haematol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="128" to="132" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b248">
	<analytic>
		<title level="a" type="main">Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hoenigl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Krause</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Pharm Des</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="3648" to="3668" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b249">
	<analytic>
		<title level="a" type="main">Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Walsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Anaissie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Denning</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="327" to="360" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b250">
	<analytic>
		<title level="a" type="main">Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Groll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Giri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Petraitis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="274" to="282" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b251">
	<analytic>
		<title level="a" type="main">High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates</title>
		<author>
			<persName><forename type="first">A</forename><surname>Juster-Reicher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Flidel-Rimon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Amitay</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="603" to="607" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b252">
	<analytic>
		<title level="a" type="main">Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients</title>
		<author>
			<persName><forename type="first">I</forename><surname>Lutsar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Roffey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Troke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="728" to="732" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b253">
	<analytic>
		<title level="a" type="main">Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hentrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Schalk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schmidt-Hieber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Oncol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="936" to="947" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b254">
	<analytic>
		<title level="a" type="main">Executive summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Pappas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Kauffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Andes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="409" to="417" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b255">
	<analytic>
		<title level="a" type="main">Imaging findings of rhinocerebral mucormycosis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Herrera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Dublin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Ormsby</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Skull Base</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="117" to="125" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b256">
	<analytic>
		<title level="a" type="main">The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial</title>
		<author>
			<persName><forename type="first">B</forename><surname>Spellberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">V</forename><surname>Chin-Hong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="715" to="722" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b257">
	<analytic>
		<title level="a" type="main">Hyperbaric oxygen as an adjunctive treatment for zygomycosis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">V</forename><surname>John</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chamilos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Kontoyiannis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="515" to="517" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b258">
	<analytic>
		<title level="a" type="main">Hyperbaric oxygen: applications in infectious disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Kaide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khandelwal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Emerg Med Clin North Am</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="571" to="595" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b259">
	<analytic>
		<title level="a" type="main">Successful treatment of rhinoorbital mucormycosis with posaconazole and hyperbaric oxygen therapy</title>
		<author>
			<persName><forename type="first">M</forename><surname>Almannai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Imran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Estrada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Siddiqui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Hematol Oncol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="184" to="186" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b260">
	<analytic>
		<title level="a" type="main">Cryptococcosis in patients with hematologic malignancies. A report from GIMEMA-infection</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pagano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fianchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Caramatti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="852" to="856" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b261">
	<analytic>
		<title level="a" type="main">Fungal pneumonia due to molds in patients with hematological malignancies</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pagano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fianchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Leone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Chemother</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="339" to="352" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b262">
	<analytic>
		<title level="a" type="main">CNS cryptococcosis in AIDS: spectrum of MR findings</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Andreula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Burdi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Carella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Comput Assist Tomogr</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="438" to="441" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b263">
	<analytic>
		<title level="a" type="main">Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends</title>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Wagener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Singh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1566" to="1576" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b264">
	<analytic>
		<title level="a" type="main">The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Rolfes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Hullsiek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rhein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1607" to="1614" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b265">
	<analytic>
		<title level="a" type="main">Imaging of central nervous system viral diseases</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Soni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Khandelwal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Magn Reson Imaging</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="477" to="491" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b266">
	<analytic>
		<title level="a" type="main">Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Davies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gonde</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol Neurosurg Psychiatr</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="82" to="87" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b267">
	<analytic>
		<title level="a" type="main">Herpes simplex virus encephalitis after allogeneic transplantation: an instructive case</title>
		<author>
			<persName><forename type="first">R</forename><surname>Romee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Brunstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Weisdorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Majhail</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="776" to="778" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b268">
	<analytic>
		<title level="a" type="main">Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Glaser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sheriff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1377" to="1383" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b269">
	<analytic>
		<title level="a" type="main">Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Lurain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zuckerman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="463" to="465" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b270">
	<analytic>
		<title level="a" type="main">Late cytomegalovirus polyradiculopathy following haploidentical CD34 + -selected hematopoietic stem cell transplantation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Zeiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Grüllich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bertz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="243" to="245" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b271">
	<analytic>
		<title level="a" type="main">Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Avery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Bolwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Yen-Lieberman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1071" to="1075" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b272">
	<analytic>
		<title level="a" type="main">A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>John</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Manivannan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chandy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transplant Proc</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="4303" to="4305" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b273">
	<analytic>
		<title level="a" type="main">Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation</title>
		<author>
			<persName><forename type="first">A</forename><surname>Worth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Conyers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cohen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="377" to="385" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b274">
	<analytic>
		<title level="a" type="main">Human herpesvirus 6 in hematological malignancies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ogata</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Exp Hematop</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="57" to="67" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b275">
	<analytic>
		<title level="a" type="main">Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1</title>
		<author>
			<persName><forename type="first">A</forename><surname>Grahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Studahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nilsson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Vaccine Immunol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1336" to="1342" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b276">
	<analytic>
		<title level="a" type="main">Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Casado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Corral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>García</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="179" to="187" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b277">
	<analytic>
		<title level="a" type="main">Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Koralnik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="425" to="437" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b278">
	<analytic>
		<title level="a" type="main">Progressive multifocal leukoencephalopathy: current treatment options and future perspectives</title>
		<author>
			<persName><forename type="first">D</forename><surname>Pavlovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Patera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Nyberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ther Adv Neurol Disord</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="255" to="273" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b279">
	<analytic>
		<title level="a" type="main">PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids</title>
		<author>
			<persName><forename type="first">K</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Roda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ostrow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="1458" to="1464" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b280">
	<analytic>
		<title level="a" type="main">Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Kleinschmidt-Demasters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Miravalle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schowinsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="604" to="617" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b281">
	<analytic>
		<title level="a" type="main">Dual therapy with cidofovir and mirtazapine for progressive multifocal leukoencephalopathy in a sarcoidosis patient</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ryoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Noh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Case Rep Neurol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="258" to="262" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b282">
	<analytic>
		<title level="a" type="main">Late relapse of progressive multifocal leucoencephalopathy postallogenic transplant in a young patient with CLL</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sanchez-Quintana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Breña-Atienza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Marrero-Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Alvarez-Acosta</surname></persName>
		</author>
		<idno type="DOI">10.1136/bcr-2013-200213</idno>
	</analytic>
	<monogr>
		<title level="j">BMJ Case Rep</title>
		<imprint>
			<date type="published" when="2013-08-05">2013 Aug 5</date>
		</imprint>
	</monogr>
	<note>epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b283">
	<analytic>
		<title level="a" type="main">Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient</title>
		<author>
			<persName><forename type="first">A</forename><surname>Balduzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lucchini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Hirsch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bone Marrow Transplant</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="987" to="992" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b284">
	<analytic>
		<title/>
		<idno type="DOI">10.1093/annonc/mdw155</idno>
	</analytic>
	<monogr>
		<title level="j"> Annals of Oncology reviews</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">7</biblScope>
			<date type="published" when="2016-07">July 2016</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
